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Abstract 
Metals are commonly found as natural 
constituents of proteins. Nature has selected particular 
metals over an evolutionary period of 2–3 billion years to 
form metalloproteins, which perform a wide range of 
fundamental biological functions.  
Metalloproteins consists of protein scaffolds and prosthetic 
groups, which contain one or more metal ions linked to the 
polypeptide chain by different types of interaction, either 
covalent or non-covalent.  
A mutual relation between metal cofactors and 
polypeptide chains is established, since (i) metal ions can 
impart particular three-dimensional folding to the protein, 
thus influencing its function/s, and (ii) the protein matrix 
is able to modulate the chemical reactivity of metal ions, 
thus selecting one reaction as the only or predominant one. 
Understanding how Nature finely tunes the properties of 
metalloproteins, imparting them such different 
chemistries, is of crucial interest both in the fields of basic 
and applied sciences.   
In this respect, this Ph.D. project was focused on 
the development of new artificial heme-protein mimetics, 
belonging to the Mimochrome family. Mimochromes1–8 are 
heme-peptide models, made up by two peptide chains, 
covalently linked to the deuteroporphyrin IX. Their global 
folding can be viewed as a sandwich, in which the peptide 
chains are in α-helical conformation and cover both planes 
of the heme, resulting in a helix-heme-helix sandwich. 
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Through an iterative process of design, synthesis, 
characterization and re-design, a penta-coordinated model 
was developed, FeIII-Mimochrome VI,7 which exhibits 
peroxidase-like activity. 
In a next stage of design, a generation of Mimochrome VI 
analogues was developed, by individually replacing Glu2 
and Arg10 on both peptide chains with a Leu residue.8 The 
four new analogues were screened for their peroxidase-
like activity. The detailed structural and functional analysis 
of the best analogue, FeIII-Glu2Leu(TD)-MC6, indicates that 
an arginine residue in proximity to the heme-distal site, 
now free from the ion pair interaction, could assist the 
catalysis by favouring the formation of the “Compound I”, 
similarly to the conserved distal arginine (Arg38) in 
Horseradish Peroxidase (HRP).9–11  
The main drawback of Mimochrome VI and its analogues 
relies in the lack of three-dimensional structures. The 
analysis of the NMR spectrum of the diamagnetic CoIII-
Mimochrome VI complex revealed the presence of multiple 
species in solution.  
In order to improve the structural properties and 
the catalytic performance of FeIII-Mimochrome VI and its 
analogues, a re-design was performed. 
Starting from FeIII-Glu2Leu(TD)-MC6, whose model is 
lacking of an inter-chain ion pair interaction with respect 
to Mimochrome VI model, some structural constrains were 
inserted. Therefore, Aib residues were introduced at 3 and 
7 positions of the decapeptide chain, obtaining a molecule, 
named Mimochrome VIa.  
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In the next stage of design, a systematic evaluation of the 
linker length between the porphyrin and the decapeptide 
chain was carried out. In particular, to further stabilize the 
sandwich structure, the linker length was progressively 
decreased. Therefore, Lys at position 9 on the decapeptide 
chain was substituted with Orn and with Dab, whose side 
chains contain, respectively, one and two methylenic group 
less than lysine side chain. In this way, two new analogues 
were obtained, named, respectively, Lys9Orn(D)-
Mimochrome VIa and Lys9Dab(D)-Mimochrome VIa. 
The Aib introduction allowed to separate two regioisomers 
for each compound, due to the coupling of the decapeptide 
to the propionic group at 2 position and of the 
tetradecapeptide at 18 position of the deuteroporphyrin, 
and vice versa. These two regioisomers, named isomer 1 
and 2, were isolated and the metal was individually 
inserted into these two species. 
The new developed enzymes were screened for their 
peroxidase-like activity. Thus, the oxidation of the reducing 
substrate ABTS (2,2’-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid), by activating H2O2, was explored. The 
functional screening highlighted that: 
  introducing Aib residues increases the stability 
toward bleaching, as shown by the higher turnover 
number; 
  decreasing the decapeptide-porphyrin linker 
length increases the catalytic activity. 
FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 have 
been selected as the best enzymes, in terms of catalytic 
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activities and turnover number. While being more than 
tenfold smaller in terms of molecular weight, FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 display 
improved enzyme-like properties, that in turn approach 
HRP. 
UV-Vis, CD, EPR and Mössbauer spectroscopies were used 
in combination to gain insight into the molecular basis of 
the catalytic improvement, correlating the primary, 
secondary and tertiary structures of the new mini-enzymes 
with the spin state of the metal ion and the nature of the 
axial ligands. It was demonstrated that the iron(III) 
coordination environment is similar to that of HRP, the 
natural parent enzyme, confirming the correctness of the 
design. 
The NMR spectrum of the cobalt complex of Lys9Dab(D)-
Mimochrome VIa isomer 2 displays a unique species, in 
contrast with the NMR spectrum the prototype, CoIII-
Mimochrome VI, which displays a more complex spectrum 
indicative of the presence of multiple species in solution. 
This result highlights that the improvement in the catalytic 
properties is accompanied by an improvement in the 
structural properties. The complete structural 
determination by NMR of CoIII-Lys9Dab(D)-Mimochrome 
VIa isomer 2 is in progress, in order to obtain information 
for useful structure-function relationship studies. 
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1.1   Metalloproteins in nature 
Metals are commonly found as natural constituents 
of proteins. It has been estimated that over 50% of all 
proteins will turn out to be metalloproteins.1 Nature has 
selected particular metals over an evolutionary period of 2–
3 billion years on the basis of their unique physicochemical 
properties and bioavailability. In proteins, metals perform a 
wide range of fundamental biological functions, spanning 
from structure stabilization to catalysis, respiration, 
metabolism, nitrogen fixation, signal transduction, 
protection against toxic and mutagenic agents and photo-
synthesis.2  
Metalloproteins are proteins that contain a metal 
ion cofactor;3 among metalloproteins, those that perform a 
catalytic function are called metalloenzymes. Many metallo-
proteins contain transition metals. They possess 
energetically accessible d orbitals, which number, shape, 
and symmetry properties contribute to the rich variety of 
spectroscopic, magnetic, and catalytic properties exhibited 
by transition metal complexes. Transition metal ions may 
form with ligands different types of bonds, from highly 
covalent to highly electrostatic.  
In general, ligands are atoms or groups of atoms 
bonded to the metal ion. They are electron pair donors 
(Lewis base) and are classiﬁed as monodentate (or 
polydentate) if one (or more) electron pair is donated to 
the metal ion. The ligands in metalloproteins are often 
derived by the polypeptide chain, and are therefore named 
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endogenous ligands. Most metal-binding sites include only 
a small number of coordinating amino acids, in a specific 
spatial arrangement. The most commonly found 
coordinating amino acid are histidine (His), cysteine (Cys), 
aspartic (Asp), and glutamic acid (Glu). On the contrary, 
tyrosine (Tyr), methionine (Met), serine (Ser), lysine (Lys), 
glutamine (Gln), asparagine (Asn), threonine (Thr), and 
glycine (Gly) less commonly coordinate the metal ion. With 
the exception of glycine, which coordinates a metal ion 
through the backbone carbonyl oxygen, the other amino 
acids participate in coordination almost exclusively 
through their side chains containing sulphur, oxygen or 
nitrogen as donor atoms. 
Metal ion preferences for a certain amino acid side 
chain follow the general rules of coordination chemistry 
and often can be interpreted using the theory of hard and 
soft acids and bases (HSAB theory). Furthermore, metal ion 
can also be coordinated by exogenous cofactor groups 
(ligands not derived from the polypeptide chain); they 
comprise small inorganic entities, such as oxide, hydroxide, 
water, as well as organic macrocyclic ligands, such as 
porphyrins, corrins, and chlorins.4 
Basically, a protein-bound metal site consists of 
one or more metal ions, all protein side chain and 
exogenous bridging and terminal ligands, that together 
define the first coordination sphere of each metal ion. Such 
sites, named prosthetic groups, can be classified into five 
basic types depending on their function: 
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(i) structural - configuration (in part) of protein 
tertiary and/or quaternary structure; 
(ii) storage - uptake, binding, and release of metals 
in soluble form; 
(iii) electron transfer - uptake, release, and storage 
of electrons; 
(iv) dioxygen binding - metal-O2 coordination and 
decoordination; 
(v) catalytic - substrate binding, activation, and 
turnover. 
The coordination is often conceived in terms of 
concentric spheres: the inner sphere containing those 
atoms interacting with the metal ion, the second sphere 
containing those atoms interacting with the inner sphere 
ligand atoms.2 The number of atoms in these spheres 
depends on the size of the metal ion and the sizes of the 
ligand atoms. There is a large distribution of coordination 
numbers and geometries among the metal ions; however, 
the most frequent coordination numbers are four and six. 
Coordination and geometry are strictly related to 
the metalloprotein function. For example, the charge 
distribution in the active site of an enzyme is designed to 
stabilize the transition state of the catalyzed reaction 
relative to that of the substrate. In enzyme-catalyzed 
reactions it is essential that the reactants be brought 
together with the correct spatial orientation, otherwise the 
chance of the reaction taking place is diminished and the 
reaction rate will be too low. The electrostatic environment 
in the active site is a major factor that serves to guide the 
substrate to the binding site in the correct orientation. 
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Metal ions can assist in this process, often binding groups in 
a stereochemically rigid manner, thereby helping to control 
the action of the enzyme. Thus, an enzyme will bind its 
substrate in such a manner that immobilization and 
alignment, ready formation of the transition state of the 
reaction to be catalyzed, and then easy release of the 
product will result; metal ions often help in accomplishing 
this process.5 
 
1.1.1 Heme-proteins 
1.1.1a Heme structure 
Heme-proteins are a class of extremely important 
macromolecules, ubiquitous in biological systems, 
characterized by a common prosthetic group: the “heme”. 
The heme chemically refers to iron ion, usually in the +2 or 
+3 oxidation states, enclosed in the center of the porphyrin, 
a large heterocyclic organic ring, in which four pyrrolic 
groups are linked together by methine bridges (Figure 1). 
 
Figure 1 Chemical structure and numbering scheme, according to 
IUPAC nomenclature of the porphyrin macrocycle. The 2, 3, 7, 8, 12, 13, 
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17 and 18 positions have commonly been referred to as beta positions, 
whereas those at 5, 10, 15 and 20 are referred to as meso positions. 
Hemoproteins can perform a wide variety of 
different functions, spanning from electron transfer,6,7 to 
catalysis,6 dioxygen transport and storage,6 ligand sensing,8 
steroid biosynthesis,9 aerobic respiration,10 photo-
synthesis,11 gene expression regulation12 and even 
programmed cell death.13 
The tetrapyrrole macrocycle is the chromophore in 
each type of natural heme-protein; its peripheral β-pyrrolic 
substituents define the type of heme, as shown in Figure 2.  
 
Figure 2 Chemical structures of commonly occurring natural hemes a, 
b, c and d. Reproduced from reference 14. 
The most common heme tetrapyrrole macrocycle 
is iron(II) protoporphyrin IX, known as heme b or 
“protoheme”. The term “heme” specifically refers to the 
ferrous complex of protoporphyrin IX. Its structure has 
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methyl groups at positions 3, 7, 12 and 17, vinyl groups at 
positions 8 and 13, and propionates at positions 2 and 18 
on the macrocycle. It is found in b-type cytochromes, 
globins, cytochromes P-450 and hemesensor proteins. 
Generally, protein scaffolds bind hemes via the combination 
of the axial coordination positions available on the iron, 
hydrophobic interactions with the heme macrocycle, and 
polar interactions with the propionic acids.14 
Heme c is structurally similar to heme b except that 
thioether bonds are formed between cysteine residues and 
the heme vinyl groups, thus covalently linking the heme 
macrocycle to the protein scaffold. Cytochromes c and 
cytochrome f, in which the heme c is found, typically 
contain a CXXCH sequence motif, in which the two cysteine 
residues link to the porphyrin macrocycle and the histidine 
binds to the encapsulated iron. The presence of a covalently 
linked heme designates it as a c-type.14,15 
Heme a is biosynthesized from heme b by 
conversion of the vinyl group at position 8 into a hydroxy-
ethylfarnesyl group, followed by subsequent oxidation of 
the methyl at position 3 to a formyl group. Therefore, heme 
a is both more hydrophobic and more electron-
withdrawing respect to its precursor. Heme a is found only 
in terminal oxidases, such as mammalian cytochrome c 
oxidase.14,16 
Other less common heme architectures include 
heme d,17 heme P-460,18 siroheme,19 and chloro-
cruoroheme.20 
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1.1.1b Protein matrix in heme-proteins 
The protein matrix plays a crucial role in 
determining the reactivity of the heme. In fact, there is a 
plethora of different functions performed by proteins 
containing the common prosthetic heme group. The protein 
composition and structural organization of the peptide 
fine-tune the environment of the heme cofactor, selecting 
one reaction as the only or predominant one. 
The amino acid composition and the structural 
organization of the peptide chain dictate the properties of 
the primary (metal coordination geometry, number, type 
and donor properties of the axial ligands) and secondary 
(local dielectric constant, hydrophobicity, hydrogen 
bonding interactions near the active site) coordination 
shells. Moreover, the protein directs long-range 
interactions. All these factors modulate heme-protein 
features, such as redox potentials, electronic structure, spin 
states, and catalytic properties.21 
Recently, the characteristics of the heme binding 
sites have been investigated in detail through 
bioinformatics.22 Different amino acids are able to serve as 
axial or proximal ligands to heme. In a data set of 
nonhomologous heme-proteins, histidine predominates as 
an axial ligand (61 occurrences in the data set), especially 
in multiheme proteins. Other residues with side chains 
acting as axial ligands are methionine, cysteine, and 
tyrosine (8, 6, and 3 occurrences in the data set, 
respectively).22 In two cases a change in axial ligand is 
observed on reduction: in CO-sensing protein the axial 
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ligand Cys75 is replaced by His77 in the reduced state,23 
while in cytochrome cd1 nitrite reductase one of the axial 
ligands (a tyrosine residue) exits from the coordination 
sphere on reduction, leaving a vacant site.24 
 
Figure 3 Occurrence of axial ligands to the heme iron ion in a data set 
of nonhomologous heme-proteins. Data from reference 22. 
The most frequently found coordination number is 
five; therefore, the most common coordination motif is five-
coordinate mono-histidine, as found for globins and 
peroxidases, in which the protein matrix provides only one 
axial ligand, leaving the sixth coordination position empty 
to accommodate exogenous molecules. The second most 
common coordination motif (one-third as often as mono-
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histidine) is six-coordinate bis-histidine, found in electron 
carriers proteins.  
As shown in Figure 3, rather frequently methionine and 
cysteine act as axial ligands to the heme. In fact, typical 
ligation motif for six-coordinate heme-proteins are 
histidine and methionine (cytochrome c)25 or bis-
methionine (bacterioferritin),26 whereas cysteine ligation is 
mainly observed in five-coordinate heme-proteins, such as 
cytochrome P-450.27 Beyond methionine and cysteine, few 
other amino acid ligands are found in six-coordinated 
heme-proteins in combination with histidine (Tyr in 
cytochrome cd1 nitrite reductase).24 In very few structures, 
some residues coordinate the heme iron through their 
neutral N-terminal amino group, such as a tyrosine in 
cytochrome f15 and a proline in CO-sensing protein.23 
Li et al. pointed out that heme binding pockets are 
enriched in aromatic and non-polar amino acids.28 Through 
bioinformatic tools, they analyzed the occurrence of amino 
acid residues in a non-redundant data set of 125 heme-
proteins. 
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Figure 4 Relative frequency of the residues in heme b (HEM), heme c 
(HEC), and heme b and c (ALL). Reproduced from reference 28. 
The top five residues with highest relative 
frequencies are cysteine (C), histidine (H), phenylalanine 
(F), methionine (M), and tyrosine (Y). Four of the top five 
(C, H, M, and Y) are able to bind iron ion as axial ligands; 
removing axial ligands from the dataset, the occurrence of 
histidine decreases to the background level, proving that 
the occurrence of histidine is mainly due to its role as heme 
ligand. The other four residues, on the other hand, have 
almost the same relative frequencies with or without ligand 
residues (Figure 5).  
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Figure 5 Relative frequency of the 5 residues with or without them as 
axial heme ligands. Reproduced from reference 28. 
In heme c proteins, the occurrence of cysteines is 
extremely high, due to the large presence of the classic 
CXXCH binding motif, as mentioned above.29 
The aromatic residues (F, Y, W) play important roles in 
protein-heme interactions through stacking interactions 
with the porphyrin. Aliphatic residues (L, I, V) are slightly 
increased over the background frequencies: they make 
hydrophobic interactions with the heme macrocycle. The 
residues with the fewest occurrences (D, E, K), are charged 
residues, suggesting the heme binding pocket is mainly a 
hydrophobic environment. 
Moving to the analysis of the heme-protein 
secondary structures, it has been observed the clear 
dominance of α-helical structures (77%), although heme-
proteins mainly composed of β-sheets or mixed α/β 
structures are not uncommon (13% and 10%, 
respectively). This analysis has been performed using the 
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CATH database, which hierarchically categorizes protein 
structure by Class, Architecture, Topology and Homologous 
superfamily.14  
 
Figure 6 A CATH wheel representation of natural heme-protein 
secondary structures: α-helical in red, β-sheet in green, mixed α/β in 
yellow. At the bottom, an example for each type: myoglobin in red, 
nitrophorin in green, and FixL in yellow. Reproduced from reference 
14. 
 
1.1.2 Peroxidases 
Peroxidases are a large family of ubiquitous 
enzymes which catalyze the oxidation of a large array of 
organic and inorganic substrates, such as phenols, aromatic 
amine, thioanisoles and iodide, using hydrogen peroxide 
(H2O2) as electron acceptor.  
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Although they are among the first enzymes to have 
been discovered, with references dating back to 1845, 
when Schönbein observed the oxidation of guaiacol in 
presence of hydrogen peroxide by certain plant tissues, 
peroxidases continue to be widely studied, proving their 
prominent position in chemistry, biotechnology and 
associated research areas (enzymology, biochemistry, 
medicine, genetics). 
Peroxidases are widely distributed among bacteria, 
fungi, plants, and animals; on the basis of their amino acid 
sequence similarities as well as functional and structural 
properties, peroxidases have been divided into three 
different superfamilies: plant peroxidases, animal 
peroxidases and catalases. 
The plant superfamily consists of peroxidases of 
prokaryotes, fungi, and plants. They can be divided into 
three major classes: class I contains intracellular 
peroxidases of bacteria, archaeans, mitochondrial 
cytochrome c peroxidases, and ascorbate peroxidases; 
classes II and III include, respectively, the secretory fungal 
peroxidases and the secretory plant peroxidases.30 This 
classification was based originally on comparisons of amino 
acid sequence, but it is well-supported by more recent 
three-dimensional structural data obtained for enzymes 
from each of the classes. 
While plant peroxidases are monomeric proteins 
with a non-covalently bound heme, animal peroxidases are 
usually dimeric with a covalently attached prosthetic 
group.  
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The remaining peroxidases are catalases, which are 
heme tetrameric enzymes that catalyse the dismutation of 
H2O2. 
All the peroxidases contain ferriprotoporphyrin IX 
as a prosthetic group, with the exception of 
myeloperoxidase,31 which contains a chlorine. The iron ion, 
in the resting state of the enzyme, is invariantly penta-
coordinated: the equatorial positions are occupied by the 
four pyrrole nitrogens of the heme, whereas in the axial 
position there is a nitrogen of an histidine (the so-called 
proximal histidine), except for chloroperoxidase which 
contains a thiolate ligand.32 The sixth coordination position 
is free, thus determining a high spin S=5/2 state for the iron 
ion. 
 
1.1.2a Horseradish Peroxidase 
The Horseradish Peroxidase (HRP) is the most 
widely studied of all peroxidases. As all the peroxidases, 
HRP occurs as a large family of different molecular forms of 
the same enzyme, named isoenzymes, which catalyse the 
same reaction but have distinct physical, chemical and 
kinetic properties, arising from small differences in their 
amino acid sequence. 
Although the term horseradish peroxidase is used 
somewhat generically, the root of the plant (Armoracia 
rusticana) contains a number of different peroxidase 
isoenzymes among which the C isoenzyme (HRP C) is the 
most abundant. This isoenzyme has been the subject of 
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much of the published work on horseradish peroxidase, 
which comprises many thousands of papers in literature. 
HRP C comprises a single polypeptide chain of 308 
amino acid residues,33 with the N-terminal blocked by 
pyroglutamate and an heterogeneous C-terminus, with 
some molecules lacking the terminal residue (Ser308). Nine 
potential N-glycosylation sites can be recognised in the 
primary sequence from the motif Asn-X-Ser/Thr and of 
these, eight are occupied.  
The total carbohydrate content of HRP C depends on the 
source of the enzyme; generally values between 18 and 
22% are typical. The carbohydrate profile is heterogeneous 
and it is mainly constituted by branched hepta-saccharides, 
many minor glycans, N-acetylglucosamines (two of them 
invariably conserved at the termini) and several mannose 
residues.34 If the carbohydrate moiety constitutes 20%, 
then the total molecular weight is around 42 kDa (this 
calculation does not account for bound water and counter 
ions). 
HRP C contains two different types of metal centre, 
iron(III) protoporphyrin IX and two calcium atoms; both 
are essential for the structural and functional integrity of 
the enzyme. 
The heme group is attached to the enzyme by a coordinate 
bond with the Nε of His170 (the proximal histidine). The 
second axial coordination position, on the distal side of the 
heme plane, is unoccupied in the resting state of the 
enzyme, but available to hydrogen peroxide binding during 
the enzyme turnover. Several other small molecules, such 
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as carbon monoxide, cyanide, fluoride and azide, are able to 
bind to the heme iron atom at this distal site.  
The two calcium ions are located at the heme distal and 
proximal positions and they are both hepta-coordinated, 
with oxygen-donor ligands provided by a combination of 
amino acids side chains (Asp carboxylates, Ser and Thr 
hydroxyl groups), backbone carbonyls and a structural 
water molecule.35  
HRP polypeptide chain folds into 13 α-helices and 
three β-sheets.36 The proper protein conformation is 
stabilized by four disulfide bonds (Cys11–Cys91, Cys44–
Cys49, Cys97–Cys301, and Cys177–Cys209). The protein 
consists of two domains, distal and proximal, between 
which the heme group is located. 
 
Figure 7 Three-dimensional representation of the X-ray crystal 
structure of horseradish peroxidase isoenzyme C (PDB entry ID: 1H57). 
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Most reactions catalysed by HRP C and other 
horseradish peroxidase isoenzymes can be expressed by 
the following equation: 
 
in which AH and A· represent a reducing substrate (such as 
aromatic phenols, phenolic acids, indoles, amines, 
sulfonates) and its radical product, respectively. 
The catalysis occurs as a three-step cyclic process, 
in which the enzyme is first oxidized by H2O2 and then 
reduced back to the native form in two sequential steps, 
involving the formation of two enzyme intermediates, 
Compounds I and II (Figure 8).36–38 
 
Figure 8 Reaction cycle of HRP, showing the enzyme intermediates, 
Compounds I and II. 
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The first step consists in the cleavage of the H2O2 
molecule, with the concomitant production of water and 
incorporation of an oxygen atom into Compound I, which 
contains an oxoferryl group, with the iron in the +4 
oxidation state, and a porphyrin π-cation radical. 
Compound I is capable of oxidizing a wide range of 
reducing substrate molecules (AH) by a mechanism 
involving a single-electron transfer, in which the π-cation 
radical is first reduced, leading to the formation of the 
second enzyme intermediate, called Compound II. 
Compound II, which also contains an oxoferryl group, is 
further reduced by a second substrate molecule (AH) to the 
native ferric enzyme (FeIII). During this one-electron 
reduction, the oxygen accepts two protons to form a water 
molecule and is released from the heme. 
Everse has proposed that the bond between the iron and 
oxygen in both Compounds I and II is not a conventional 
double bond. In fact, except for its length, all experimental 
observations indicate that the oxoferryl bond may be a bi-
radical, three-centre four electron π-bond.39 
One of the key factors in the modulation of the 
redox potential of the penta-coordinated complex is the 
presence of a strong hydrogen bond between the Nδ atom 
of the proximal histidine and an aspartate side chain 
(Asp247): this increases the basicity of the coordinating 
histidine His170, thus stabilizing high oxidation state 
intermediates, such as the high valent oxoferryl center, by a 
charge relay system.2 
The binding of H2O2 occurs in the distal site, which 
is characterized by two completely invariant amino acids in 
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all plant peroxidases: the distal histidine and the distal 
arginine (Figure 9). These two residues play a major role in 
the formation and stabilization of Compound I. The distal 
histidine (His42) mainly acts as a general acid–base 
catalyst, facilitating the peroxide anion binding to the heme 
and assisting the subsequent heterolytic cleavage of the O–
O bond during the Compound I formation.40 The conserved 
distal arginine (Arg38) is involved in the charge 
stabilization, mediated by its positively charged 
guanidinium group, of the developing OH- leaving group of 
hydrogen peroxide. Further, once the O–O bond is cleaved, 
Arg contributes to stabilize the oxoferryl species via 
hydrogen bond formation.  
 
Figure 9 Detail of the proximal and distal sites of HRP (PDB entry ID: 
1H57). 
Phe41 
His42 
Asn70 
His170 
Asp247 
Arg38 
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The key role of these highly conserved residues has 
been proved, since their replacement causes a drastic 
reduction of Compound I rate formation, and therefore of 
HRP catalytic activity.41–43 
Reaction of excess hydrogen peroxide with resting 
state enzyme gives Compound III, whose structure is best 
described as a resonance hybrid of Fe2+-O2 and the 
isoelectronic Fe3+-O2-· form. Recently, Berglund and co-
workers succeeded in obtaining a three-dimensional movie 
of the X-ray-driven catalytic conversion of the bound 
dioxygen species to two molecules of water in the active 
site.44 The mechanism involves four successive, one-
electron, reductions with the concomitant uptake of a 
proton, from Compound III to the ferrous HRP, via the 
intermediate forms of Compound I, Compound II and ferric 
HRP. The high-resolution crystal structure of Compound III 
shows dioxygen bound to heme iron in a bent 
conformation.44 
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1.2 From natural to artificial 
metalloproteins 
As highlighted above, almost half of all known 
proteins contain metal cofactor(s) that are able to serve 
numerous roles, either structural or functional, such as 
respiration, water oxidation, molecular oxygen reduction 
and nitrogen fixation. It is remarkable that, despite the 
variety of functions in which metalloproteins are involved, 
the number of utilized metal–based prosthetic groups is 
relatively small. In fact, such different chemistries are 
determined by the protein matrix, which influences the 
environment of the metal cofactor, regulating its catalytic 
activity and stability.2 Understanding at a molecular level 
the mechanism by which the protein part acts, is of 
fundamental importance in both basic and applied science, 
to shed light on the detailed mechanisms of fundamental 
biological processes, and to allow researchers to construct 
new metalloproteins with desired properties and functions.  
Most fundamental aspects of metal cofactor 
assembly and metalloproteins functions have already been 
clarified, mainly through structural–functional studies on 
natural metalloproteins and related mutants. For example, 
it has been shown that modification of a single amino acid 
residue can profoundly affect the activity of the enzyme.45 
Despite these progresses, several questions are still open. 
While the control of the functional specificity by the 
primary coordination sphere is almost well understood, the 
contribution of medium and long range interactions 
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remains to be determined. Thus, it is not surprising that 
many efforts are being devoted to the development of 
metalloprotein mimics aimed to: 
   provide further insights for structure-activity 
relationships; 
   understand the minimal requirements for function; 
   reproduce the properties of the parent natural 
proteins in smaller molecules, with improved 
properties, such as higher stability and greater 
efficiency; 
   construct new, tailor-made molecules useful for 
biomedical, pharmaceutical, biological, and 
environmental applications.  
Metalloprotein design is more challenging than the 
design of non-metalloproteins, since it requires a properly 
folded protein scaffold, which has to include the correct 
number and type of ligands to determine the appropriate 
geometry for metal center reactivity. On the other hand, 
most metal-binding sites are highly chromatic and display 
distinctive magnetic properties, allowing easier 
characterization by means of spectroscopic techniques 
rather than X-ray crystallography or nuclear magnetic 
resonance (NMR), thus shortening design cycles.46  
The protein design process can be divided into two steps: 
the design of the overall scaffold and the design of active 
sites. Although the design of the overall scaffold and active 
sites are linked, it is helpful to distinguish these two steps 
because our knowledge about each step is still not 
complete.47  
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There are several design approaches: de novo 
design, design or re-design of new metal-binding sites into 
native scaffolds, and minimalist approach. 
De novo design or design “from scratch” of a 
metalloprotein involves constructing a polypeptide 
sequence that is not directly related to any natural protein 
and that folds precisely into a defined three-dimensional 
structure that binds a metal ion.2 Numerous papers in this 
area have been published, focused on introducing metal-
binding sites into de novo designed α-helical bundles, which 
are one of the most common scaffolds in nature. In stark 
contrast to the design of α-helical proteins, few successful 
examples of other de novo designed scaffolds have been 
reported.46 
Another equally attractive design strategy is the 
design of active sites into native scaffolds.47 In fact, 
evaluating numerous structures in the Protein Data Bank, it 
emerges that there are many more natural than de novo 
designed protein scaffolds: moreover, several natural 
protein scaffolds maintain the same fold and similar 
stability upon mutation. Therefore, metalloprotein design 
using native instead of de novo protein scaffolds may 
provide more scaffold choices, assuming that they are 
tolerant to mutations, required for the construction of the 
metal-binding sites.46  
The redesign of an existing metal-binding site to 
introduce new function or metal specificity is amenable to 
empirical approaches, and relies on the structural 
differences between template and target proteins. Despite 
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its simplicity, this approach is still powerful in elucidating 
structural features important for the change in, or gain of, 
function by redesign.46 It is known that biochemical 
techniques, such as site-directed mutagenesis, have been 
used extensively to study structure-function relationship in 
metalloproteins; for example, the loss of activity 
accompanied by a mutation of highly conserved residues 
allows the identification of residues essential for function. 
Although serving a different purpose, the same 
mutagenesis techniques can be used in metalloprotein 
design to impart a new function into a protein scaffold by 
introducing residues that bind metal ions.  
Another powerful approach involves a 
miniaturization process, suitable to build the minimal 
peptide sequence, which contains sufficient information for 
proper folding and for an accurate reconstruction of the 
active site structure.2 This approach holds the advantage 
that the designed systems are generally simple enough, and 
therefore they can be easily synthesized and characterized, 
and simultaneously the polypeptide sequences are of 
sufficient size and chemical diversity to accommodate the 
metal binding site. The miniaturization process can be 
rationally organized once a structural knowledge of the 
parent natural system to be miniaturized is available. It is 
necessary to define: (1) the type and number of 
constituents to be assembled, (2) the structure to be 
reconstructed, and (3) the function to be reproduced. These 
aspects are strictly related. Metalloproteins are well suited 
to be miniaturized. As illustrated in Figure 10, the metal 
center represents a pivot point where spheres of variable 
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diameters that circumscribe part of the protein are 
centered.48,49 The larger the diameter of the sphere, the 
larger the number of constituents included in the model. 
For a sphere of a given diameter around the metal center, 
the constituents therein circumscribed are, in general, 
unconnected parts. Several strategies can be conceived to 
obtain a miniaturized model. Two or more parts could 
spontaneously associate to give folded non-covalent self-
assembled oligomers, or two or more parts could be 
covalently connected to give folded monomers. 
 
Figure 10 The full structure of rubredoxin (left) (PDB code: 8RXN), 
whose active site can be dissected in two symmetry-related idealized β-
hairpins, residues 5–12, and 38–45 (right). Reproduced from reference 
2. 
Design is often aided by empirical approaches 
based on prior knowledge and experience, the use of 
computer programs (rational design) or combinatorial 
selections. Although approaches based on empirical 
knowledge and rational design using computer programs 
have been quite successful in designing metalloproteins, it 
is still difficult to design certain metalloproteins, especially 
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functional ones, owing to the large number of potential 
interactions within the active site of a metalloenzyme. In 
this case, combinatorial design and directed evolution of 
new metalloenzymes is another powerful method.46 
An invaluable tool in providing support for design 
is spectroscopy, although more concrete evidence from 
three-dimensional structural characterization is essential. 
In addition, to confirming the initial design, it provides 
detailed information on what has not been designed 
correctly, thus providing insights for the next step of 
design. Furthermore, design of the primary coordination 
sphere is often not enough to confer structure and/or 
function; consideration of the environment surrounding the 
primary coordination sphere is critical to successful design. 
As a result, the rational engineering of metallo-proteins is 
an iterative process of design, synthesis and rigorous 
characterization, until the desired characteristics are 
obtained. The complexity of protein structures, where a 
copious number of molecular interactions contributes to 
the stabilization of the folding and to the fine adjustment of 
the properties of metal cofactor, makes necessary several 
redesign cycles, often following a trial and error process. 
Nevertheless, metalloprotein design will remain an exciting 
and challenging field in which researchers will continue to 
spend their efforts in designing metalloproteins with novel 
functions or improved properties. 
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1.2.1 Heme-peptide models 
Peptide-based models have been fundamental in 
assisting our understanding of the factors governing the 
heme properties. Standing at the crossroads of small 
molecule models and large proteins, they seem to be the 
best candidates to mimic both the structural characteristics 
and reactivity of the natural systems. Their structures are 
simpler than their natural counterparts, but they 
simultaneously have sufficient size and chemical diversity 
to allow substrate recognition and to reproduce the 
efficient chemio-, regio-, and stereoselectivity of natural 
heme-proteins.  
The development of peptide-based models takes 
advantage of recent progress in both the design and 
synthesis of peptides and proteins. It is now possible to 
construct recognition and catalytic sites in a scaffold and to 
systematically vary the amino acid composition, thus 
allowing one to (1) optimize the structural and functional 
properties of the initial target, in terms of stability, catalytic 
activity and selectivity, (2) test how small changes in the 
sequence can affect the heme properties and functions and 
(3) investigate not only the effect of variation in the first 
coordination sphere but also the influence on the activity of 
medium- and long-range interactions.21 
It is possible to distinguish two main types of 
peptide-based heme-protein models: covalent and non-
covalent. Here only the models in which peptide chains are 
covalently linked to the heme will be examined. 
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Over the years, heme protein models have been 
developed using quite different strategies. They differ in 
molecular structures, ranging from simple meso-
substituted tetra-arylmetalloporphyrins to more complex 
peptide-porphyrin conjugates.50 The chemical structures of 
porphyrins usually employed in this model systems are 
reported in Figure 11. 
 
Figure 11 Chemical structures of porphyrin rings: a) protoporphyrin 
IX; b) deuteroporphyrin IX; c) mesoporphyrin IX; d) mesoporphyrin II; 
e) coproporphyrin; f) meso-tetraphenylporphyrin. 
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A common feature in the compounds so far 
developed is the assembly, around the porphyrin ring, of 
several different chemical components, which are intended 
to fulfill the features of the protein matrix and make the 
heme able to accomplish specific functions. 
For example, to obtain oxygen carrier models, two main 
requirements are needed: (1) stabilization of a penta-
coordinated complex provided by an imidazole proximal 
ligand and (2) prevention from further oxidation of the 
iron-dioxygen complex.51 In the natural systems these 
mandatory conditions for efficient reversible oxygen 
binding are accomplished by the presence of the steric 
bulkiness of the protein moiety, which prevents the 
formation of a μ-oxo bridge between two heme complexes 
and brings the axial ligand in the appropriate position.  
An artificial model for the dioxygen activation should 
embody the following features: (1) an axial thiolate ligand, 
which contributes to the heterolytic cleavage of O-O bond 
and modulates the intrinsic reactivity of the high valent 
iron-oxo species; (2) a steric protection of the porphyrin 
ring to prevent the rapid bleaching of the catalyst by the 
oxidizing species produced during the reaction; (3) a chiral 
environment around the heme, able to selectively recognize 
a defined substrate, and to control the chemio-, regio- and 
stereoselectivity in oxygenation reactions.52–54 
The first low molecular weight heme-protein 
models date back to the early 1970s. All these systems 
show penta-coordination, obtained both by using hindered 
ligands and by covalently attaching the axial ligand to the 
porphyrin ring. A bulky moiety is needed to cover one face 
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of the porphyrin ring, preventing the formation of an hexa-
coordinated specie. The bulky moiety could also represent 
a cavity in which dioxygen can be accommodated.51  
The pioneering works of Traylor,55,56 Collman,54 
Momenteau,57 and Reed58,59 can be considered fundamental 
for the development of dioxygen binding molecules; they 
combined more than one of the above mentioned 
strategies. Some representative examples are constituted 
by the picnic-basket,60 picket-fence54 and capped56 
porphyrin systems, where the coordination state of the 
iron(II) is achieved by using hindered substituents on the 
meso or the pyrrole positions of a 5, 10, 15, 20-
tetraphenylporphyrin (Figure 12). 
 
Figure 12 Dioxygen binding model compounds: (a) picnic-basket, (b) 
picket-fence and (c) capped porphyrin. Reproduced from reference 50. 
These systems can be considered fundamental for 
the development of dioxygen binding molecules and have 
contributed to a better understanding, at a molecular level, 
of the properties of the natural heme-proteins. Even though 
they display enhanced and interesting activity, their 
practical application is limited to the use in organic solvent. 
In more recent years, the field of heme-protein 
mimetics broadens to include more elaborate peptide-
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based models. The works on chelated hemes, which are 
characterized by a imidazole or pyridine ligand covalently 
bound to the propionic group of pyrro-, proto-, meso- and 
deuteroheme,55,61 represent milestones to demonstrate the 
importance of covalently derivatized porphyrin rings and 
to set the stage for the development of more sophisticated 
models.  
Peptide-based models seem to be better candidates 
to mimic both the structural characteristics and reactivity 
of the natural systems. Peptide architecture around the 
heme can serve for substrate recognition and to reproduce 
the efficient chemio-, regio-, and stereoselectivity of natural 
heme-proteins. Peptide models stand at the crossroads of 
small molecule models and large proteins. Their structures 
are simple and hence more easily understood than their 
natural counterparts. They simultaneously have sufficient 
size and chemical diversity to allow the construction of 
functional binding and catalytic sites.62–65 
Quite different strategies were used for developing 
covalent peptide-porphyrin systems. The development of 
peptide-based models takes advantage of recent progress 
in both the design and synthesis of peptides and proteins. It 
is now possible to construct rigid scaffolds able to 
accommodate substantial changes in their sequence 
without loosing their three-dimensional structure because 
the principles governing folding and stability of peptides 
and proteins are better understood and advanced tools for 
their design are available.65–72 Hence, it is possible to build 
recognition and catalytic sites in a scaffold and to 
systematically vary the amino acid composition, thus 
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allowing one to: (1) optimize the structural and functional 
properties of the initial target, in terms of stability, catalytic 
activity and selectivity, (2) test how small changes in the 
sequence affect the properties of the heme and whether 
they are able to switch the heme function from one to 
another, and (3) investigate not only the effect of variation 
in the first coordination sphere but also the influence on 
the activity of medium- and long-range interactions. 
Peptide models offer the additional advantage of 
solubilizing the high hydrophobic heme in aqueous solution 
by simply accommodating the heme group in a 
hydrophobic pocket of an amphiphilic structure. Finally, the 
functional parameters can be improved with an iterative 
process of redesign and synthesis.  
Microperoxidases (MPs) are natural covalent 
heme-peptide fragments, which can be obtained by the 
proteolytic digestion of cytochromes c.73,74 Their peptide 
moiety is covalently linked to the heme c through thioether 
bounds, since contains the Cys-(Xaa)2-Cys motif. Being 
provided with the proximal histidine of the parent 
cytochrome c, microperoxidases are characterized by a 
mono-histidine coordination. To date no crystal structure of 
any microperoxidase has been reported. It has been 
suggested that the peptide retains a conformation very 
similar to that of the amino acid residues of the parent 
protein. In horse heart cytochrome c the N-terminal 
residues up to Cys14 are part of an a-helix that terminates 
with a type III β turn between Cys14 and Cys17.75 
Molecular dynamics simulation of MP8 and MP11 suggests 
that the peptide is confined to shielding the proximal face 
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of the porphyrin and the distal face is completely open to 
solvent. MP8 in aqueous solution has its amino acids largely 
arranged as a torus in a plane parallel to the porphyrin.76 
 
Figure 13 Three of the most commonly studied microperoxidases 
(MPs): MP11, MP9 and MP8. The amino acid residue numbering is that 
of the parent cytochrome c from horse heart. Reproduced from 
reference 76. 
MP8, MP11 and their derivatives were proved to be 
effective catalysts in oxidation and oxygenation reactions. 
However, the applications of microperoxidases as mini-
enzymes are significantly limited by their tendency to 
aggregate in aqueous solutions and their low stability 
under catalytic conditions. Accessibility of the distal side 
causes degradation of the porphyrin ring during catalysis, 
either by the direct action of H2O2 or by reactions with 
another active iron-oxo species. Nevertheless, the peptide 
moiety plays an important protective role toward the 
bleaching of the catalyst, if one consider that the nude 
protoporphyrin is less stable than Microperoxidases.21 
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Casella and co-workers first reported synthetic 
deuteroheme-peptide conjugates in an attempt to study 
how peptide sequences influence the heme reactivity.77–82 
The molecular models of these deuteroheme complexes, 
developed as both mono-peptide and bis-peptide adducts, 
are shown in Figure 14. 
 
Figure 14 Molecular structures of chelated deuteroheme complexes: 
(A) deuteroheme undecapeptide; (B) chelated deuteroheme 
undecapeptide; (C) chelated deuteroheme. Reproduced from reference 
21.  
The covalent modification of deuteroheme with different 
peptides was simply achieved by employing the solution 
methods of peptide synthesis.77,78 The synthesis of the 
chelated deuteroheme mono-peptide complexes usually 
afforded a mixture of two products containing the peptide 
linked at either position 2 or 18 of deuteroheme. Only in a 
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few cases were these structural isomers separated; 
otherwise the isomer mixture was studied. 
In the first molecule developed, an undecapeptide was 
covalently N-terminally linked to the propionic group of 
deuteroheme (Figure 14A).77 This medium sized peptide 
contains polar and acidic residues, which should confer 
solubility to deuteroheme in a protic medium. The presence 
of the peptide chain strongly influences the binding and 
catalytic properties of deuteroheme. First, titration of 
deuteroheme undecapeptide with imidazole, followed by 
visible spectroscopy, showed that the complex binds up to 
two imidazoles. The binding equilibrium occurred in two 
steps: the first imidazole binds with high affinity, while the 
affinity for the second imidazole is markedly lower. The 
authors hypothesized that the folding of the peptide chain 
in the mono-imidazole adduct greatly limits the 
accessibility to the sixth iron coordination position. The 
catalytic properties of the deuteroheme-undecapeptide 
complex in peroxidase- and catalase-like reactions were 
investigated by using thioanisole or tyrosine as substrates 
and hydrogen peroxide as oxidant. In the catalytic oxidation 
of D- and L-tyrosine, the complex exhibited some 
stereoselectivity ascribed to specific interactions between 
the substrate and the peptide chain. 
In subsequent works, the same investigators developed 
chelated deuteroheme complexes in an effort to study the 
effects of the axial ligand on the catalytic properties of 
deuteroheme.78 In these new systems, a histidine 
methylester or a histidine containing dipeptide, covalently 
linked to one of the two propionic groups, constituted the 
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chelating arm (Figure 14B). A different peptide chain was 
linked to the second propionic group, rationally chosen 
with the aim of evaluating the effect of specific amino acids 
in inducing stereoselective oxidation. 
Two complexes, each containing a different phenylalanyl-
polyalanine sequence, were studied (Figure 14B).78 The 
kinetic parameters for the catalytic oxidation of D- and L-
tyrosine, using tert-butyl hydroperoxide, revealed a 
marked difference in the chiral discrimination ability of the 
two complexes, suggesting that the Phe residue position 
influences the chiral discrimination. 
The analysis of the axial-ligand distortion effects on the 
catalytic and binding properties of deuteroheme was 
investigated by examining the behavior of complexes 
bearing short chelating arms: DH-His, DH-Ala-His, and DH-
Gly-His (Figure 14C).79,80 Molecular mechanics calculation 
revealed the length of the chelating arm critically affects the 
coordination. The presence of two amino acid residues in 
the chelating arm causes less strain in the axial 
coordinative bond with respect to the DH-His complex. The 
strain energy influences the catalytic and binding 
properties of the metal center, as a consequence of an 
altered electron distribution in the strained complex. 
Benson and co-workers developed a series of 
peptide-sandwiched mesoheme complexes, indicated as 
PSMs.83–86 In PSMs the mesoheme II or IX is covalently 
linked to one or two peptide chains via an amide linkage 
between the propionate heme function and the Nε of lysine 
residues. A His residue in each peptide coordinates the 
heme iron, thus allowing the peptide chains to fold above 
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and below the porphyrin ring, giving rise to a sandwich 
structure.83  
One of the main features of PSM molecules is that a random 
coil-helix transition of the peptides occurs upon histidine to 
iron binding. The first derivatives of the PSMs series are 
characterized by the presence of a 13-residue peptide 
covalently linked to the mesoheme propionic groups. The 
peptide was designed to have high helical propensity and to 
convey water solubility to the structure. A polyalanine 
sequence, containing Glu residues in the solvent-exposed 
position, was created. Lys and His were placed into the 
sequence to achieve the covalent linkage to the porphyrin 
and the iron coordination, respectively.  
To rationalize the factors that impart stability to the PSMs 
molecules, new derivatives were developed.84 By changing 
the Lys-His separation, the chelate effect and the resulting 
strain in the Fe-His axial bond were evaluated. In addition, 
in some derivatives, the position of Lys was changed from 
N- to C-terminus, i.e., reversed peptide sequences were 
synthesized.  
The UV-Vis, CD, and EPR analysis of both mono- and bis-
peptide adducts revealed that stability of PSMs is 
controlled by several factors. In all derivatives His is able to 
coordinate the iron, giving rise to pentacoordinated high-
spin species in the mono-adducts and low-spin 
hexacoordinated species in the bis-adducts. It was 
demonstrated that an important factor that modulates the 
stability of PSMs is the length of the chelating arm, i.e., the 
distance between Lys and His residues.  
A series of α-helical peptides covalently linked to 
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heme were also studied by Mihara and co-workers.87,88 
They developed two three-helix bundle proteins, 3α-H9 and 
3α-H12, covalently bound to meso-heme IX as models of 
peroxidases.88 The distal His ligand was placed in different 
positions within the two systems to regulate six- or five-
coordination of the heme iron.  
The two molecules showed different activities toward the 
oxidation of o-methoxyphenol to tetra-guaiacol using 
hydrogen peroxide as oxidant. In particular, a good 
correlation was found between the coordination states of 
the heme and the catalytic efficiency of the systems, i.e., the 
molecule containing a higher content of five-coordination 
showed the best activity. However, the accessibility of 
hydrogen peroxide and its destructive effect toward the 
heme should be carefully balanced in order to enhance the 
activity. 
More recently, a new artificial heme-enzyme, MP3, 
has been designed, by combining the excellent structural 
properties of four-helix bundle protein scaffolds with the 
activity of natural peroxidases.89 It houses two peptide 
chains of different composition covalently linked the 
deuteroporphyrin IX through the side chain of two lysine 
residues, to obtain an asymmetric helix–loop–
helix/heme/helix–loop–helix sandwich arrangement. MP3 
is a penta-coordinated complex, characterized by: a 
histidine residue on one chain as axial ligand to the heme 
iron; an empty distal site able to accommodate exogenous 
ligands or substrates; an arginine residue in the distal site 
that should assist in hydrogen peroxide activation, 
mimicking Arg38 in HRP.  
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Figure 15 Computer model of MP3. A trace representation of the 
helices with key residues depicted as sticks. Reproduced from 
reference 89. 
MP3 has been synthesized and characterized as its 
iron complex. CD spectroscopy suggests that MP3 scaffold 
possesses a high intrinsic helical propensity in water, even 
if complete folding of the helices occurs only in the 
presence of the helix-inducing solvent TFE (2,2,2-
trifluoroethanol); UV/Vis, MCD and EPR spectroscopies 
give insight into the coordination geometry and spin state 
of the metal, confirming mono-His coordination above pH 4. 
MP3 shows a high catalytic turnover and efficiency in the 
oxidation ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid)) by H2O2, with a kcat value only eight-fold 
lower than that of HRP under the experimental conditions 
for maximal activity for each enzyme, but ten-fold higher 
than that of HRP at neutral pH. 
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1.2.2 Mimochromes 
The Artificial Metallo-Enzyme Group in Naples, 
where this work has been carried out, has approached the 
challenge of constructing heme-protein models using a 
miniaturization process. Thanks to this strategy, a class of 
artificial heme-proteins has been developed, named 
Mimochromes. 
Mimochromes are peptide-sandwiched deutero-
heme systems, obtained by miniaturizing natural heme-
proteins, in order to partially reproduce their structural 
and functional properties in smaller compounds. Analyzing 
natural heme-protein structures, it emerges that the 
prosthetic group is almost completely embedded between 
two relatively small α-helical peptide fragments. 
The natural motif helix/heme/helix was used as a 
template to engineer the family prototype, Mimochrome 
I.90–92 To design a mini-heme protein, the copious 
interactions of the peptide moiety with the heme 
commonly found in natural proteins were replaced by a few 
strong local constraints. The smallest sequence required for 
a complete coating of one face of the heme, was identified 
in a nine-residue peptide, based on the F helix of 
hemoglobin β-chain (Figure 16).  
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Figure 16 Three-dimensional representation of the X-ray crystal 
structure of human deoxyhemoglobin. Insert: E and F helixes in the β-
chain; the F helix was used to design Mimochrome I peptide sequence. 
Mimochrome I peptide sequence contains: a 
central His residue to coordinate the heme iron; Leu 
residues at positions i-4 and i+4 relative to the His to 
hydrophobically interact with the heme macrocycle; a 
lysine residue to anchor the heme group; two alanine 
residues (that substitute Ser89 and Cys93), chosen for their 
high α-helical propensity; a glutamine and an asparagines 
residues (that substitute Glu90 and Asp94), to remove 
charge residues that could destabilize the target 
conformation (Figure 17).  
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Figure 17 Schematic structure of Mimochrome I and comparison 
between its peptide sequence and L88-L96 fragment of the F helix in 
the β-chain of hemoglobin. 
Deuteroporphyrin IX was preferred to the more 
common protoporphyrin IX to avoid the possibility of 
degradation of the sensitive vinyl substituents during the 
synthesis. Two identical copies of the peptide were 
covalently linked to the porphyrin propionic groups 
through the ε-amino function of Lys, obtaining a pseudo-C2-
symmetric dimer (Figure 18).90 
 
Figure 18 Molecular model of FeIII-Mimochrome I. Reproduced from 
reference 90. 
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Interestingly, the insertion of cobalt ion into the 
porphyrin ring gave two diastereomers. In fact, the 
flexibility of the linker between the peptide and the 
deuteroporphyrin ring allows each peptide chain to be 
positioned either above or below the porphyrin plane, 
producing enantiomeric configurations around the metal 
center. The presence of the substituents on the porphyrin 
ring and the chirality of the peptide chain make the Δ and Λ 
isomers of Co(III)-Mimochrome I diastereomeric forms. 
This finding was confirmed by structural NMR 
characterization of the two previously separated Co(III) 
complexes.92  
 
Figure 19 Front, side and top views of the average molecular 
structures obtained from NMR data and RMD calculations for Δ isomer 
(top) and Λ isomer (bottom) of Co(III)-Mimochrome I. Reproduced 
from reference 21. 
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The information derived from Mimochrome I was 
applied for improving the design. Over the years, other 
models have been developed, with the same or different 
peptide chains linked to the deuteroporphyrin ring (Table 
1).  
 
Table 1 Peptide sequences of the developed Mimochromes. 
 
Mimochrome II93 presents two identical and 
elongated peptide chains, modeled in an extended 
conformation, whose residues carefully chosen in order to 
improve water solubility and to stabilize a unique 
diastereomer.  
Later on, another complex with identical peptide 
chains was designed: Mimochrome IV.94–96 This model 
considers intra-molecular inter-helical interactions, 
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provided by an ion pair between the carboxylate side chain 
of a Glu residue at position 1 of one peptide chain and the 
guanidine group of an Arg residue at position 9 of the other 
peptide chain (both side chains being modelled in an 
appropriate extended conformation). Moreover, the helix is 
further stabilized by a positively charged residue (Arg) at 
the C-terminus, and a negatively charged residue (Glu) at 
the N-terminus, which reduce the intensity of the helix 
dipole. 
Mimochrome IV was the first molecule with a unique 
topology of the Mimochrome family. Its Co(III) complex 
was extensively characterized both in solution and solid 
state, confirming the presence of the Λ topology (Figure 
20). The structural characterization evidenced that in the 
solid state crystal packing interactions strongly affects the 
molecular folding, with intra-chain Glu1–Arg9 ion pairs 
that are preferred over the designed, and experimentally 
found in solution, inter-chain interactions. 
Figure 20 NMR (on the left) and X-ray (on the right) structures of 
Co(III)-Mimochrome IV. 
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1.2.2a Mimochrome VI and its analogues 
Since Mimochrome IV, despite its small size, adopts 
a unique well-defined secondary and tertiary structure, the 
next goal was to introduce peroxidase-like activity into 
Mimochrome’s architecture.  
Peroxidases are very appealing for oxidation 
reactions, because they have high activity towards a wide 
range of substrates; despite this, their high production 
costs and bleaching during catalysis limit their potential 
applications. Therefore, it would be better use simpler 
artificial metalloenzymes with improved stability and 
efficiency. 
Among the Mimochrome family, Mimochrome VI 
was the first model showing catalytic functionality.97 It is 
made up by a 14-residue peptide with a His residue at 
position 6, as axial ligand to the heme (proximal site) and a 
10-residue peptide lacking a heme-coordinating residue, to 
create a cavity around the metal ion (distal site). This 
unsymmetrical penta-coordinated mono-His model was 
designed starting from the NMR solution structures of both 
the symmetric bis-His Mimochrome II and Mimochrome IV.  
The tetradecapeptide was designed to adopt a 
short helical conformation (residues 1-9), a loop γβD 
(residues 10 and 11) and a short β-strand (residues 12-14) 
that folds back to interact with the helical part; the 
decapeptide also was designed to adopt a helical 
conformation (residues 1-8). Stabilization of the secondary 
structure is also contributed by the positively charged 
Arg10 and the negatively charged Glu2 at the C-terminal 
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and N-terminal ends, respectively, with the opposite sign 
relative to the helix dipole. 
The tertiary structure can be viewed as a sandwich, 
characteristic of the Mimochrome family, in which the two 
peptide chains embrace the metalloporphyrin; the helixes 
of the peptide chains are antiparallel to each other and the 
helix axes are about parallel to the porphyrin plane. 
Stabilization of the tertiary structure is enhanced by inter-
chain ion pairs between the carboxylate side chains of a 
glutamate residue (Glu2) on one helix and the guanidine 
group of an arginine residue (Arg10) on the other helix. 
Finally, several glutamines (Gln3, 4 and 8) and a serine 
(Ser7) were introduced in the solvent exposed positions to 
promote water solubility. 
 
Figure 21 Molecular model and amino acid sequence of FeIII-
Mimochrome VI. Reproduced from reference 97. 
Catalysis experiments showed that FeIII-
Mimochrome VI behaves like a very promising artificial 
peroxidase, as it catalyses oxidation reactions by the 
activation of H2O2.  
In the oxidation of ABTS, none of the synthetic models 
developed so far has kcat as high as that of HRP   (kcat = 4100 
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s-1, pH 4.6). FeIII–Mimochrome VI approaches the catalytic 
performance of the natural enzyme, since it has a kcat value 
only 11-fold lower than that of HRP, in the experimental 
conditions for maximal activity for each enzyme, and a kcat 
value of FeIII–Mimochrome VI almost 7-fold higher than 
that of HRP at neutral pH. 
 
Table 2 Catalytic parameters for the oxidation of ABTS (AH2) by H2O2 
activation for Mimochrome VI and HRP in the experimental conditions 
for maximal activity for each enzyme. 
 
The specific activity of FeIII-Mimochrome VI is comparable 
with that of highly purified HRPs (1.0·102 mmol g-1 s-1 and 
1.4·102 mmol g-1 s-1, respectively, for ABTS oxidation); this 
highlights both its high catalytic efficiency and small 
molecular mass, compared to natural peroxidases. 
Moreover, it exhibits multiple turnover kinetics: more than 
4000 turnovers within 10 min in the ABTS oxidation. 
FeIII-Mimochrome VI also catalyzes: the oxidation 
of guaiacol, with a kcat value 50-fold lower than that of HRP; 
the conversion of phenols to 4- and 2-nitrophenol in 
presence of NO2 and H2O2 in high yields; the tyrosine 
coupling. 
Recently, the ability of FeIII-Mimochrome VI 
adsorbed on mesoporous ITO (indium tin oxide) electrodes 
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to perform the electrochemical reduction of molecular 
dioxygen has been proved.98 This encouraging results will 
lead to a more detailed study of the mechanism of this 
reaction, in order to open the way of Mimochrome VI’s 
applications in electrochemical biosensor development. 
Finally, FeIII-Mimochrome VI was used in 
combination with antibodies aimed to develop more 
sensitive immunochemical detection assays, offering high 
performance and economic benefits. In fact, thanks to its 
low molecular weight (3.5 kDa), it is possible to increase 
the conjugation ratio enzyme/antibody, which results in a 
signal amplification. To date, it was possible to obtain 
antibodies (polyclonal human IgG) functionalized with 
about 13 molecules of this mini-enzyme: this enzyme/ 
antibody ratio is significantly higher respect to the 
commercial immunoglobulins, which are usually linked to 3 
or 4 HRP molecules. These conjugates retain the catalytic 
activity, and immunoreactivity assays are in progress.99 
All these features indicate FeIII–Mimochrome VI as 
an attractive low-molecular-weight enzyme, and 
encouraged to further design, in order to improve the 
catalytic properties and to gain insight into the structure-
activity relationship. 
In the next stage of design, the attention was 
focused on Glu2 and Arg10, in both deca and tetradeca 
chains, since both peptides are involved in finely tune the 
reactivity. In Mimochrome VI design, these residues were 
placed at the N- and C- termini, respectively, to contribute 
to stabilize both secondary and tertiary structures. By 
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individually replacing Glu2 and Arg10 on both peptide 
chains with a Leu residue, four analogues were obtained, 
which were screened for peroxidase-like activity.100 
 
Figure 22 On the left, FeIII-Mimochrome VI molecular model, 
highlighting the R10-E2 ion pair interactions. On the right, peptide 
sequences of FeIII-Mimochrome VI (MC6) and its analogues: acid, basic 
and non-polar residues in position 2 and 10 are indicated in red, blue 
and green, respectively. Reproduced from reference 100. 
The peroxidase activity towards ABTS was 
evaluated in the same condition used for FeIII-Mimochrome 
VI (MC6): 50 mM phosphate buffer pH 6.5, 50% TFE (v/v), 
T=25 °C. The apparent catalytic constant of the analogues 
substituted on the tetradeca chain are about 2-fold higher 
with respect to MC6. The best performances were obtained 
for E2L(TD)-MC6, which displays improvement in the 
apparent catalytic constant (kcat = 7.8·102 s-1), and catalytic 
efficiency for both H2O2 and ABTS (kcat/Km = 25 mM-1 s-1, 
and 16·103 mM-1 s-1, respectively). In contrast, the 
analogues with the altered deca chain showed an almost 
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unmodified reactivity compared with MC6, and the worst 
one among them is E2L(D)-MC6 analogue. 
All MC6 analogues were able to perform several thousands 
of turnovers, without bleaching. The turnover numbers 
(T.O.N.) reflects the trend of the catalytic efficiency, being 
higher in E2L(TD)-MC6 and lower in R10L(TD)-MC6. 
 
Table 3 Steady-state kinetic parameters for FeIII-Mimochrome VI 
(MC6) and its analogues, in the same experimental conditions (50 
mM phosphate buffer pH 6.5, 50 % TFE (v/v), T=25 °C). 
Reproduced from reference 100. 
 
A detail spectroscopic characterization allowed to 
hypothesize a catalytic role of Arg10 on the decapeptide 
chain, whose side chain may approach the heme, 
contributing to stabilize Compound I and helping ligand 
binding, similarly to the conserved distal arginine (Arg38) 
in HRP. In fact, there is experimental evidence that the 
E2L(TD)-MC6 catalytic cycle occurs with a peroxidase-like 
mechanism, through the formation of Compound I, proving 
its similarity with natural peroxidases, whose reactivity is 
influenced by the proximal and distal heme 
environments.100 
The main drawback of Mimochrome VI and its 
analogues relies in the lack of three-dimensional structures. 
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The analysis of the NMR spectrum of the diamagnetic CoIII-
Mimochrome VI complex revealed the presence of different 
species in solution. The availability of a three-dimensional 
structure would allow us to:  
   verify the correctness of the design; 
   obtain a more detailed structure-activity 
relationship for the next step of design. 
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1.3 Aim of the project 
This PhD project has been focused on the 
development of new low molecular weight, stable and cost-
effective artificial heme-enzymes, which couple high 
activity with a well-defined structure for biosensing and 
diagnostic applications.  
In particular, the two main objectives which this 
project aims to, are: 
   improving the catalytic performance of FeIII-
Mimochrome VI and its analogues; 
   overcoming the presence of multiple species in 
solution, which made the attempts to solve the 
structure of Mimochrome VI  unsuccessful. 
These two objectives are strictly related, since the 
availability of a unique and well-defined three-dimensional 
structure will allow an accurate structure-activity 
relationship analysis that will help in redesigning the 
enzyme with improved catalytic performance. 
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2.1 The new Mimochrome VIa 
generation: design and 
synthesis 
The new developed Mimochromes generation has 
been designed with the aim of introducing some structural 
constraints that should stabilize the three-dimensional 
sandwich structure, typical of Mimochromes, while 
preserving or enhancing functionality. 
As described above, recently the role of the inter-
chain ion pairs in Mimochrome VI model has been 
explored, designing a new family of analogues containing 
point amino acid substitutions. In particular, by 
individually replacing Glu2 and Arg10 on both peptide 
chains with a Leu residue, four analogues were obtained, 
which have been screened for their peroxidase-like 
activity.1 The best catalytic performances were obtain for 
Glu2Leu(TD)-Mimochrome VI, allowing us to hypothesize a 
catalytic role of Arg10 on the decapeptide chain, whose side 
chain may approach the heme, contributing to stabilize 
Compound I and helping ligand binding, similarly to the 
conserved distal arginine (Arg38) in the Horseradish 
Peroxidase (HRP).  
Starting form this point, we chose to conserve the 
Glu2Leu substitution on the tetradecapeptide chain, 
interrupting an inter-chain ion pair interaction in 
Mimochrome VI model (Glu2(TD)-Arg10(D)). To 
compensate for the destabilization caused by this 
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substitution, some structural constrains were introduced. 
Specifically, substitutions were introduced on the 
decapeptide chain, since it most likely experiences higher 
conformational freedom, respect to the tetradecapeptide 
chain, due to the lack of the coordinating histidine, that 
firmly anchors the tetradecapeptide chain on the heme. The 
α-aminoisobutyric acid (Aib, single letter code: U), was 
introduced in 3 and 7 positions of the decapeptide chain, 
obtaining Gln3,Ser7Aib(D)Glu2Leu(TD)-Mimochrome VI, 
named Mimochrome VIa.  
                                                  
Figure 23 Primary sequence and molecular model of FeIII-Mimochrome 
VIa. Amino acid substitutions with respect to FeIII-Mimochrome VI are 
in green, negatively charged residues are in red and positively charged 
residues are in blue.  
The α-aminoisobutyric acid, or 2-amino-2-
methylpropanoic acid, is a natural, non-coded amino acid, 
with a very high helical propensity, commonly found in 
peptides produced by microbes.2 The replacement of the 
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hydrogen atoms with methyl groups at the Cα of the glycine 
produces sever restrictions on its conformational freedom: 
for Aib-containing peptides it is strongly favored the 
formation of α-, 310- or mixed α-/310-helix secondary 
structures (Figure 24). Moreover, it has been shown that 
the equilibrium between the α- and 310-helix in Aib-
containing peptides is strongly influenced by changes in 
several parameters, mainly including the peptide length 
and the Aib content.3 Several studies have shown that Aib 
oligomers form exclusively 310-helices. On the contrary, if 
the Aib content does not exceed 50%, the 310-helix is 
preferred for shorter peptides (number of residues, n, 8 or 
less), whereas a α-helix is observed for longer peptides   
(n= 9-20).4,5  
Figure 24 On the left, molecular structure of the Aib residue. On the 
right, Ramachandran plot of a Aib containing peptide: red indicates the 
highest percentage of the population, and white indicates that a region 
is not populated. 
In the next stage of design, a systematic evaluation 
of the linker length between the porphyrin and the 
decapeptide chain was carried out. In particular, to further 
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stabilize the sandwich structure, the linker length was 
progressively decreased. Therefore, Lys (2,6-
Diaminohexanoic acid) at position 9 on the decapeptide 
chain was substituted with Orn (2,5-Diaminopentanoic 
acid) and with Dab (2,4-Diaminobutyric acid), whose side 
chains contain, respectively, one and two methylenic group 
less than lysine side chain. In this way, 
Gln3,Ser7AibLys9Orn(D)Glu2Leu(TD)-Mimochrome VI and 
Gln3,Ser7AibLys9Dab(D)Glu2Leu(TD)-Mimochrome VI 
were obtained, named, respectively, Lys9Orn(D)-
Mimochrome VIa and Lys9Dab(D)-Mimochrome VIa. 
 
 
Figure 25 A) Schematic structure of the new developed analogue, FeIII-
Mimochrome VIa, highlighting Lys9 residue on the decapeptide chain. 
(B) Molecular structure of Lys, Orn and Dab residues. 
A) 
B) 
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Mimochrome VIa and its analogues were 
synthesized using the strategy previously adopted for other 
Mimochromes,6 with some differences (for further details 
see Chapter IV: Materials and methods). 
Peptide chains were synthesized in solid phase, by using 9-
fluorenylmethoxycarbonyl (Fmoc) protection strategy. A 
super acid labile resin was used in order to obtain fully 
protected peptides, apart from Lys9, Orn9 and Dab9 
residues on the decapeptide chain and Lys9 on the 
tetradecapeptide chain. For Lys side chain, the Mmt 
protecting group was chosen; Orn and Dab were used with 
Mtt protecting group on their side chain amino functions.  
The selective removal of Mmt ((4-
methoxyphenyl)diphenylmethyl) protecting group from 
residues on the two chains, allowed to obtain the fully 
protected peptides, except from Lys9. Thanks to this 
strategy, it is possible to selectively couple peptides to the 
deuteroporphyrin IX (DPIX). 
For Lys9Orn(D)-Mimochrome VIa and Lys9Dab(D)-
Mimochrome VIa, the selective removal of Mtt ((4-
methylphenyl)diphenylmethyl) protecting group allowed 
the coupling of the decapeptide chains to the DPIX. 
In order to optimize the mono-substituted porphyrin 
formation (D-DPIX) and minimize the undesired bi-
substituted product (D-DPIX-D), the decapeptide was 
slowly added to the solution containing an excess of 
deuteroporphyrin IX.  
Interestingly, the new developed Mimochrome mono-
substituted derivatives show a chromatogram profile 
evidencing two peaks of similar intensities, with the same 
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UV-Vis spectrum. The ESI-MS analysis on the two peaks 
reveals that they have the same mass spectra, whose values 
are in agreement with the mass values expected for the 
mono-substituted compound. The analytical 
chromatograms, the UV-Vis spectra and the ESI-MS spectra 
of Dab9Lys(D)-Mimochrome VIa mono-substituted 
derivative are reported in Figure 26-28, as an example. 
Similar behaviors were observed for the other two mono-
substituted porphyrin derivatives. 
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Figure 26 Top: RP-HPLC profile of Dab9Lys(D)-DPIX mono-substituted 
derivative; the peaks were detected at λ= 210 nm (in magenta), and 
400nm (in blue). Bottom: overlap of the UV-Vis spectra of the two 
peaks. 
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Figure 27 ESI-MS spectrum of the peak at Rt=49.91 min. The spectrum 
is in agreement with the expected mass (calculated mass: 2584.04 Da; 
experimental mass: 2583.7 ± 0.5 Da). 
Figure 28 ESI-MS spectrum of the peak at Rt=50.88 min. The spectrum 
is in agreement with the expected mass (calculated mass: 2584.04 Da; 
experimental mass: 2583.2 ± 0.9 Da). 
 
The two peaks were separated by HPLC on a small scale, 
and analyzed by NMR, proving that they correspond to two 
constitutional isomers (data not shown). In fact, covalent 
modification of the DPIX at one of the propionic acid groups 
gives an equimolar mixture of the isomers substituted at 2 
or 18 positions of the DPIX ring (Figure 29).  
[M-2H+]/2 
[M-Na+-H+]/2 
[M-Na+-H+]/2 
[M-2H+]/2 
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Figure 29 Molecular structures of the mono-substituted derivative of 
Mimochrome VIa and its analogues. 
The presence of two peaks in the HPLC analysis of the 
mono-substituted derivative was never observed in the 
previous Mimochromes compounds. Probably, the presence 
of the two Aib residues allowing the observed separation, 
imparts different structural properties. 
Attempts to separate the two peaks by direct phase flash 
chromatography were not successful, due to their similar 
Rf. On the other hand, reversed phase chromatography on a 
preparative scale cannot be performed, due to the acidic 
elution conditions, which remove the side chain protecting 
groups. 
Therefore, the solution containing both mono-substituted 
derivatives was then used to perform the coupling with the 
tetradecapeptide. Once obtained the bi-substituted 
products, the remaining protecting groups were removed 
from both peptide chains. Purification by preparative RP-
HPLC succeeded in separating the two regioisomers, named 
isomer 1 and 2. 
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For each new analogue, iron was individually inserted, 
following the acetate method, on the two isomers. For a 
more detailed description of protocols and synthetic 
results, please refer to Chapter IV: Materials and methods.  
The chromatographic and mass data of all the analyzed 
molecules are reported in Table 4. 
 
 
Table 4 Chromatographic data and mass data of all the synthesized 
molecules. A Vydac C18 column (4.6 mm·150 mm; 5 μm), was used in 
the LC-MS analysis, eluted with H2O/0.1% TFA (v/v) (solvent A) and 
acetonitrile/0.1% TFA (v/v) (solvent B) linear gradient, from 10% to 
50% B over 60 min, at 0.5 mL·min-1 flow rate. 
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2.2 Catalytic screening of FeIII-
Mimochrome VIa and its 
analogues 
The catalytic properties of the new developed 
Mimochromes were evaluated to determine the effects of 
point amino acid substitutions on function.  
In particular, the peroxidase-like activity towards 
the reducing substrate ABTS (2,2'-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid)) was assayed. ABTS 
is a compound of choice for the assay of peroxidase 
activity,7 since it can be efficiently oxidized in a mono 
cationic radical form (ABTS+·), which exhibits a brilliant 
green color (λmax = 660 nm) and therefore its formation can 
be easily detected by spectrophotometric measurements. 
 
Figure 30 Oxidation reaction of ABTS by H2O2. 
The kinetic parameters were determined by 
analysing, at fixed catalyst concentration, the dependence 
of the reaction rate on the concentration of one substrate 
(as example, ABTS) at saturating concentration of the other 
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(as example, H2O2), and vice versa. The experimental data 
were fitted with a two substrate Michaelis-Menten kinetic 
equation: 
 
  (α) 
 
where: 
   [E]0 is the enzyme concentration at the initial time 
(t0), which is supposed to be constant and not 
inactivated; 
   kcat (also called turnover number) is the catalytic 
constant and denotes the maximum number of 
enzymatic reactions catalysed per second; 
   [A] and [B] represent the ABTS and H2O2 
concentrations, respectively; 
   KmA and KmB are the Michaelis-Menten constants for 
ABTS and H2O2, respectively. The Michaelis-Menten 
constant is the substrate concentration at which 
the reaction rate is half of vmax and represents the 
enzyme apparent affinity for the substrate;  
The analysis of the experimental kinetic data by Michaelis-
Menten fitting provides the following catalytic parameters: 
   kcat (above discussed); 
   KmABTS and KmH2O2 (above discussed); 
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   kcat/KmABTS and kcat/KmH2O2, which are measures of 
the catalytic efficiency. 
FeIII-Mimochrome VIa and its analogues were 
screened for their peroxidase-like activity, in the same 
conditions used for FeIII-Mimochrome VI and its first 
generation of analogues (50 mM phosphate buffer pH 6.5, 
50% TFE (v/v)). The enzyme concentration was fixed at 
2.0∙10-8 M. To study the dependence towards the oxidizing 
substrate, ABTS concentration was fixed (1.0∙10-4 M), 
whereas H2O2 concentration was varied in the range of 
1.0∙10-4-1.0∙10-1 M; on the contrary, to study the 
dependence towards the reducing substrate, H2O2 
concentration was fixed (1.0∙10-2 M), whereas ABTS 
concentration was varied in the range 5.0∙10-6-1.0∙10-4 M. 
All the new developed Mimochrome enzymes follow a two 
substrate Michaelis-Menten kinetic model, as evidenced by 
inspection of Figure 31-33. 
The kinetic parameters obtained by fitting the experimental 
data with the equation (α) are reported in Table 5. The 
kinetic parameters of the parent molecule, FeIII-
Mimochrome VI, of the best catalyst of the previous 
generation of Mimochromes, FeIII-E2L(TD)-MC6, and of the 
natural reference model, HRP, are also reported in the 
Table for comparison. 
In a different experiment, the turnover number 
(T.O.N.) of FeIII-Mimochrome VIa and its analogues was 
determined. The T.O.N. is defined as the number of moles of 
substrate that a mole of catalyst can convert before 
becoming inactivated. In order to assess the turnover 
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number of the new developed molecules, the peroxidase-
like activity was studied at fixed ABTS (1.0∙10-4 M) and 
H2O2 (3.0∙10-3M) concentrations and at decreasing catalyst 
concentrations, in the range 2.0∙10-8 M – 9.0∙10-9 M (Figure 
34). The red kinetic curves reported in Figure represent the 
minimum enzyme concentration at which it is still possible 
to oxidize all the ABTS molecules present in solution, which 
can be deduced by the achievement of the plateau of the 
ABTS+· absorbance. These concentration values were used 
to calculate the TONs of all the new developed analogues, 
which are reported in Table 5, and compared with those of 
FeIII-Mimochrome VI, FeIII-E2L(TD)-MC6 and HRP. 
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Figure 31 Peroxidase-like activity of FeIII–Mimochrome VIa isomer 1 
and 2 in 50 mM phosphate buffer pH 6.5, 50% TFE (v/v). On the left, 
initial rate of ABTS oxidation at various ABTS concentrations 
(experimental condition: [H2O2]= 1.0∙10-2 M); on the right, initial rate of 
ABTS oxidation at various H2O2 concentrations (experimental 
condition: [ABTS]= 1.0∙10-4 M). The enzyme concentration is fixed at 
2.0∙10-8 M. 
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Figure 32 Peroxidase-like activity of FeIII–Lys9Orn(D)-Mimochrome 
VIa isomer 1 and 2 in 50 mM phosphate buffer pH 6.5, 50% TFE  (v/v). 
On the left, initial rate of ABTS oxidation at various ABTS 
concentrations (experimental condition: [H2O2]= 1.0∙10-2 M); on the 
right, initial rate of ABTS oxidation at various H2O2 concentrations 
(experimental condition: [ABTS]= 1.0∙10-4 M). The enzyme 
concentration is fixed at 2.0∙10-8 M. 
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Figure 33 Peroxidase-like activity of FeIII–Lys9Dab(D)-Mimochrome 
VIa isomer 1 and 2 in 50 mM phosphate buffer pH 6.5, 50% TFE  (v/v). 
On the left, initial rate of ABTS oxidation at various ABTS 
concentrations (experimental condition: [H2O2]= 1.0∙10-2 M); on the 
right, initial rate of ABTS oxidation at various H2O2 concentrations 
(experimental condition: [ABTS]= 1.0∙10-4 M). The enzyme 
concentration is fixed at 2.0∙10-8 M. 
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Figure 34 T.O.N. of all the new developed Mimochromes. Progress 
curves for ABTS oxidation in the following experimental conditions: 
[ABTS]= 1.0∙10-4 M, [H2O2]= 3.0∙10-3 M at different catalyst 
concentration, in 50 mM phosphate buffer pH 6.5, 50% TFE  (v/v). 
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2.2.1 Effect of pH on catalytic activity 
First, the role of the pH on the peroxidase-like 
activity of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 
2 was evaluated. At fixed ABTS, H2O2 and enzyme 
concentrations (1.0∙10-4 M, 3.0∙10-3M and 2.0∙10-8 M, 
respectively) the initial rate of the oxidation reaction of 
ABTS was measured in 50 mM phosphate buffer, 50% TFE 
(v/v) at different pHs.  
Figure 35 Initial rates of the ABTS oxidation as a function of pH, for 
FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 (left) and 2 (right). 
Experimental conditions: [ABTS]= 1.0∙10-4 M, [H2O2]= 3.0∙10-3 M, 
[enzyme]= 2.0∙10-8 M in 50 mM phosphate buffer, 50% TFE (v/v) at 
different pHs. 
FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 display 
the highest activity at pH 6.5 ± 0.1 and 6.6 ± 0.1, 
respectively. The parent molecule, FeIII-Mimochrome VI, 
and all the molecules of the first generation of Mimochrome 
VI analogues exhibit the highest activity at the same pH 
(within the experimental error). This finding suggests that 
the amino acid mutation does not affect the pH at which the 
maximum activity is observed. 
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2.3 Spectroscopic characterization 
of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 and 
2 
FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 
were selected for a detailed spectroscopic characterization 
in order to gain insight into their structures. These 
molecules have been chosen on the basis of their highest 
kcat and T.O.N. values, which makes them the most 
promising catalysts of the new generation of Aib-containing 
Mimochromes. 
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2.3.1 Exploring the coordination 
properties: UV-Vis characterization 
To explore the coordination properties, an UV-Vis 
pH titration was performed in the range 2.0-9.0, in 
H2O/TFE 50/50 (v/v) (Figure 36-37). 
The titration was performed by using concentrated 
solutions of trifluoroacetic acid (TFA) and sodium 
hydroxide (NaOH), in a 1.0 cm path length cuvette. Data 
points were fitted to an equation describing the 
protonation state of the species involved in the pH-
dependent equilibria.1 
For FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1, 
one well-resolved transition with midpoint at pH 6.9 ± 0.1 
was observed. It was not possible to determine the pKa in 
the pH range 2.0-5.0, because at pH 2.0 the plateau is still 
not reached (see Figure 36 b). The spectrum at this pH 
value can be attributed to a mixture of mainly high-spin bis-
H2O and His-H2O ferric complexes. 
At pH 5.0, the Soret bands is at 388 nm, the Q bands at 493 
and 530 nm, and the charge-tranfer (CT) band at 618 nm: 
these observations are consistent with a His/H2O ferric ion 
axial coordination, predominantly in high spin state.6,9 At 
pH around 8.0, the Soret band shifts to 389 nm, the Q band 
is observed as a shoulder at 514 nm; the main bands at 487 
and 600 nm are attributed to the CT bands of the mainly 
high-spin ferric hydroxide complex.10,11 These 
spectroscopic features suggest that the transition with 
midpoint at pH 6.93 corresponds to a ligand exchange from 
H2O to OH-.  
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Figure 36 a) UV-Vis spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 (5.0∙10-6 M) in H2O/TFE, 50/50 (v/v) at various pHs (2.0–9.0). 
The arrows indicate the observed intensity changes of the Soret, Q and 
CT bands at increasing pHs. b) Plot of the absorbance at 389 nm as 
function of pH. The black dots are the experimental data, which were 
fitted with a one transition model (red line). 
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Figure 37 a) UV-Vis spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2 (6.0∙10-6 M) in H2O/TFE, 50/50 (v/v) at various pHs (2.5–9.0). 
The arrows indicate the observed intensity changes of the Soret, Q and 
CT bands at increasing pHs. b) Plot of the absorbance at 389 nm as 
function of pH. The black dots are the experimental data, which were 
fitted with a two transitions model (red line). 
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For FeIII-Lys9Dab(D)-Mimochrome VIa isomer 2, 
two well-resolved transitions were observed, with 
midpoint at pH 3.9 ± 0.1 and 6.8 ± 0.1 (Figure 37 b). 
At pH around 3.0, the spectrum is typical of a 
predominantly high spin ferric porphyrin, with the Soret 
band at 387 nm, the Q bands at 491 and 528 nm, and the CT 
band at 614 nm. An increase in the pH from 3.0 to 5.3 
causes a decrease in intensity and a slight red shift of the 
Soret (388 nm) and CT bands (615 nm): these observations 
are consistent with the change in the ferric ion axial 
coordination from H2O/H2O to His/H2O.6,9 At pH around 
8.0, the Soret band shifts to 390 nm, the Q band appears as 
a shoulder at 524 nm; the band at 488 and 602 nm can be 
attributed to the CT band of the ferric complex with the 
hydroxide ion mainly in the high spin state.10,11 Therefore, 
also for FeIII-Lys9Dab(D)-Mimochrome VIa isomer 2, the 
second transition corresponds to a ligand exchange in the 
ferric ion axial coordination from H2O to OH-. 
Finally, for both isomers at increasing pHs, the 
band at 345 nm broadens and the relative intensity of this 
band to the Soret band changes from 0.2 (at pH 2.5) to 0.57 
(at pH 9). Even though the presence of a broad band at 
around 350 nm has been sometimes attributed to 
intermolecular heme–heme association,12 experimental 
evidence suggests that this is not the case for FeIII–
Lys9Dab(D)-Mimochrome VIa isomer 1 and 2. In fact, a 
linear correlation, in aqueous neutral solutions, between 
absorbance and concentration in the range 10-7–10-5 M, 
indicates a negligible association phenomena (data not 
shown).  
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2.3.2 Analysis of the secondary structure: 
CD spectroscopy in the far-UV region 
The secondary structure of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 and 2 and its dependence on 
TFE content was investigated by circular dichroism (CD) in 
the far-UV region (190-260 nm). 
On the basis of the UV-Vis titration, the spectra were 
acquired at pH 5.0 and 9.0, at which one predominant 
species is present in solution (His/H2O and His/OH-, 
respectively, relative to the ferric ion axial coordination). 
Moreover, the spectra were acquired at the pH of highest 
activity (6.5). 
 
Figure 38 Far-UV CD spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 (5.0∙10-6 M) in phosphate buffer 20 mM pH 5.0 at various TFE 
percentages (v/v), acquired in a 1.0 cm path length cuvette. 
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Figure 39 Far-UV CD spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 (5.0∙10-6 M) in phosphate buffer 20 mM pH 9.0 (top) and 6.5 
(bottom) at various TFE percentages (v/v), acquired in a 1.0 cm path 
length cuvette. 
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The TFE is a co-solvent known for its capability to 
stabilize helical structure in peptides.13–15 The spectra at 
higher TFE content are characterized by a negative band 
around 222 nm (amide transition n-π*), a negative band 
between 203-207 nm (amide transition π-π*) and a 
positive band around 190 nm (amide transition π-π*, 
perpendicular coupling), which are all typical features of a 
helical arrangement of the peptide chains.16 
In particular, the transition from random coil to helix is 
identifiable by some characteristic spectral changes: 
   increase in the absolute value of the mean residue 
ellipticity at 222 nm ([θ]222); 
   increase in the ratio between [θ]222 and [θ]min 
values ([θ]ratio), progressively closer to the unity; 
   shift of the wavelength of [θ]min (λmin) towards 207 
nm; 
   shift of λ0 towards higher values. 
In Table 6-8, the main parameters of the far-UV CD spectra 
of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 are 
reported. 
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Table 6 Parameters of the far-UV CD spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 in phosphate buffer 20 mM at pH 5.0 at 
various TFE percentages (v/v). 
 
 
Table 7 Parameters of the far-UV CD spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 in phosphate buffer 20 mM at pH 9.0 at 
various TFE percentages (v/v). 
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Table 8 Parameters of the far-UV CD spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 in phosphate buffer 20 mM at pH 6.5 at 
various TFE percentages (v/v). 
The parameters of the far-UV CD spectra of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 are very similar at 
all the three explored pHs. Increasing the TFE content up to 
50% (v/v), it is possible to observe that: 
   [θ]222 increases in absolute value from 4200 to 
15000 deg cm2 dmol-1 res-1; 
   [θ]min increases in absolute value from ≈ 10000 to  
≈ 19000 deg cm2 dmol-1 res-1; 
   [θ]ratio increases from 0.4 to 0.8; 
    λmin shifts from 202 nm to 207 nm; 
    λ0 shifts from 194 nm to 200 nm. 
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To further investigate the helix formation, the 
mean residue ellipticity at 222 nm was reported as a 
function of TFE content at the three explored pHs: 
 
  
Figure 40 Plot of [θ]222 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 in phosphate buffer 20 mM at 
pH 5.0 (top) and 9.0 (bottom). 
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Figure 41 Plot of [θ]222 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 in phosphate buffer 20 mM at 
pH 6.5. 
There is a sigmoidal trend of the experimental 
data, which confirm a mainly α-helical conformation of the 
peptide chains.15 The peptide chains, poorly structured in 
water, fold into a helix upon addition of 35%, 25% and 30% 
TFE (v/v) at pH 5.0, 9.0 and 6.5, respectively. 
The same experiments have been performed on 
FeIII-Lys9Dab(D)-Mimochrome VIa isomer 2 (Figure 42-
43). In Table 9-11 the main parameters of the far-UV CD 
spectra are reported. 
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Figure 42 Far-UV CD spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2 (5.0∙10-6 M) in phosphate buffer 20 mM pH 5.0 (top) and 9.0 
(bottom) at various TFE percentages (v/v), acquired in a 1.0 cm path 
length cuvette. 
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Figure 43 Far-UV CD spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2 (5.0∙10-6 M) in phosphate buffer 20 mM pH 6.5 at various TFE 
percentages (v/v), acquired in a 1.0 cm path length cuvette. 
Table 9 Parameters of the far-UV CD spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 2 in phosphate buffer 20 mM at pH 5.0 at 
various TFE percentages (v/v). 
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Table 10 Parameters of the far-UV CD spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 2 in phosphate buffer 20 mM at pH 9.0 at 
various TFE percentages (v/v). 
 
Table 11 Parameters of the far-UV CD spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 2 in phosphate buffer 20 mM at pH 6.5 at 
various TFE percentages (v/v). 
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For FeIII-Lys9Dab(D)-Mimochrome VIa isomer 2 
also, the parameters of the far-UV CD spectra are very 
similar at all the explored pHs. Increasing the TFE content 
up to 50% (v/v), the main changes detectable in the spectra 
are that: 
   [θ]222 increases in absolute value from 3600 to 
12000 deg cm2 dmol-1 res-1; 
   [θ]min increases in absolute value from ≈ 9000 to     
≈ 16000 deg cm2 dmol-1 res-1; 
   [θ]ratio increases from 0.4 to 0.8; 
    λmin shifts from 202 nm to 207 nm; 
    λ0 shifts from 194 nm to 200 nm. 
Therefore: the shifts of λmin and λ0 are the same for both 
isomers; at all the TFE percentages, [θ]222 and [θ]min of the 
isomer 2 are lower in absolute value than those of the 
isomer 1, but their variation is such that the increase in 
[θ]ratio upon TFE addition is identical for the two isomers. 
In Figure 44-46, the plots of the mean residue 
ellipticity at 222 nm as a function of the TFE content at all 
the three investigated pHs are reported. 
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Figure 44 Plot of [θ]222 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 in phosphate buffer 20 mM at 
pH 5.0. 
 
Figure 45 Plot [θ]222 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 in phosphate buffer 20 mM at 
pH 9.0. 
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Figure 46 Plot of [θ]222 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 in phosphate buffer 20 mM at 
pH 6.5. 
For this isomer, there is also a sigmoidal trend of 
the mean residue ellipticity at 222 nm as a function of TFE 
percentage. The plateau, for each pH value concerned, is 
reached by adding the same percentages of TFE for the two 
isomers (35%, 25% and 30% TFE (v/v) at pH 5.0, 9.0, and 
6.5, respectively). 
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2.3.3 From secondary to tertiary 
structure: CD spectroscopy in the Soret 
region 
In order to elucidate the peptide-heme interactions 
in the sandwiched structure, the CD spectra of the two new 
developed enzymes were acquired also in the Soret region 
(300-460 nm) at pH 5.0, 6.5 and 9.0. For each investigated 
pH, the dependence of the CD spectra on the TFE content 
was explored. 
The CD spectra of FeIII-Lys9Dab(D)-Mimochrome 
VIa isomer 1 in 10 mM phosphate buffer pH 5.0 and 6.5, at 
different TFE percentages (v/v) are reported in Figure 47 
and 48, respectively.  
 
Figure 47 CD spectra in the Soret region (300-460 nm) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 (1.5∙10-5 M) in phosphate 
buffer 10 mM pH 5.0 at various TFE percentages (v/v), acquired in a 1.0 
cm path length cuvette. 
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Figure 48 CD spectra in the Soret region (300-460 nm) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 (2.1∙10-5 M) in phosphate 
buffer 10 mM pH 6.5 at various TFE percentages (v/v), acquired in a 1.0 
cm path length cuvette. 
As shown in Figure 47-48, the shape and the 
intensity of the induced Cotton effect in the Soret region is 
related to the solvent composition. At pH 5.0, the spectrum 
displays a negative induced Cotton effect, centered at 386.4 
nm, whose intensity increases by increasing the TFE 
concentration. At pH 6.5 and without TFE, the spectrum is 
S-shaped with a λ0 at 398 nm; by adding TFE, the positive 
induced Cotton effect decreases in intensity, so that at TFE 
content higher than 15%, only the negative induced Cotton 
effect (centered at 386.4 nm) is detected. The dependence 
on TFE content of [θ]386.4 and [θ]404.2, at each investigated 
pH, is reported in Figure 49, 50 and 51. 
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Figure 49 Plot of [θ]386.4 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 in phosphate buffer 10 mM at 
pH 5.0. 
 
 
Figure 50 Plot of [θ]404.2 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 in phosphate buffer 10 mM at 
pH 6.5. 
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Figure 51 Plot of [θ]386.4 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 in phosphate buffer 10 mM at 
pH 6.5. 
The increase in absolute value of the induced Cotton effect 
intensity at pH 5.0 follows a sigmoidal trend, reaching a 
plateau at 40% TFE (Figure 49).  
The positive Cotton effect at pH 6.5 decreases upon TFE 
addition (0-15%); on the contrary, the negative induced 
Cotton effect intensity increases in absolute value by 
increasing the TFE content from 15 up to 40% (Figure 50-
51). 
At pH 9.0, a weak S-shaped Cotton effect is found, centered 
at 398.0 nm, whose intensity decreases up to zero upon 
TFE addition. At 50% TFE, a weak negative induced Cotton 
effect is found (data not shown).  
 
The same experiments were performed on FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2. For this isomer, a 
similar behaviour to this found for the isomer 1 was 
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observed in the Soret region as a function of pH and TFE. At 
pH 5.0 a negative induced Cotton effect was observed, 
centered at 386.0 nm, whose intensity increases by 
increasing the TFE concentration (Figure 52). At pH 6.5 and 
without TFE, the observed spectrum is S-shaped, with a λ0 
at 399.4 nm; by adding TFE, only one negative induced 
Cotton effect, centered at 386.8 nm, is detected (Figure 53).  
  
Figure 52 CD spectra in the Soret region (300-460 nm) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 (1.8∙10-5 M) in phosphate 
buffer 10 mM pH 5.0 at various TFE percentages (v/v), acquired in a 1.0 
cm path length cuvette. 
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Figure 53 CD spectra in the Soret region (300-460 nm) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 (1.8∙10-5 M) in phosphate 
buffer 10 mM pH 6.5 at various TFE percentages (v/v), acquired in a 1.0 
cm path length cuvette. 
  
 
Figure 54 Plot of [θ]386 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 in phosphate buffer 10 mM at 
pH 5.0. 
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Figure 55 Plot of [θ]386.8 as a function of TFE percentage (v/v) of FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 2 in phosphate buffer 10 mM at 
pH 6.5. 
The increase in absolute value of the induced 
Cotton effect intensity at pH 5.0 and 6.5 follows a sigmoidal 
trend, reaching a plateau at 40% and 45% TFE, respectively 
(Figure 54 and 55).  
At pH 9.0, without TFE, no Cotton effect is detected. By 
adding TFE up to 50%, a weak negative Cotton effect is 
found (data not shown).  
The main parameters of the CD spectra in the Soret 
region of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 
in phosphate buffer 10 mM pH 5.0, 6.5 and 9.0 with 
different TFE content, are summarized in Table 12. 
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Table 12 Main parameters of the CD spectra in the Soret region (360-
400 nm) of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 2. The 
missing values (--) are lower than 1.5∙103 deg cm2 dmol-1 in absolute 
value. λmax values are reported in parenthesis. 
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2.3.4  Spin state: Mössbauer spectroscopy 
The characterization of the most active complexes 
by Mössbauer spectroscopy was performed in 
collaboration with Prof. Franc Meyer Group at the Institute 
of Inorganic Chemistry, Georg-August University in 
Göttingen (Germany). 
Mössbauer spectra have been collected on FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 in solid state 
(lyophilized from acid conditions), at T= 6K. 
 
Figure 56 Mössbauer spectrum of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 in solid state at T = 6K. Circles are the experimental data, 
which have been fitted with a two-states model (red line, sum of green 
and blue lines).   
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Figure 57 Mössbauer spectrum of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2 in solid state at T = 6K. Circles are the experimental data, 
which have been fitted with a two-states model (red line, sum of green 
and blue lines).   
The Mössbauer spectra of both isomers show the presence 
of two species, and therefore have been fitted with a two-
states model (red line, Figure 56-57), whose deconvolution 
returns two one-species spectra (green and blue lines, 
Figure 56-57).  
Mössbauer spectra of both isomers have been also 
acquired at 80 and 200 K (Figure 58-59). The main 
parameters characterizing the Mössbauer spectra of these 
two species of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 
and 2 at the three explored temperatures are reported in 
Table 13. 
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Figure 58 Mössbauer spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 in solid state at T = 80K (top) and 200K (bottom). 
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Figure 59 Mössbauer spectra of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2 in solid state at T = 80K (top) and 200K (bottom). 
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Table 13 Isomer shift (δ), quadrupole splitting (ΔEQ), full width half 
maximum (FWHM) and relative intensity of the two observed species 
in the Mössbauer spectra of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 
1 and 2 at the indicated temperatures. 
From the analysis of the parameters reported in 
Table 12, at T = 6K we can deduce that both isomers in 
solid state are a mixture of two spin states in about 1:1 
(precisely 53:47) ratio. In particular, these species are the 
same for the two isomers. The first state has δ and ΔEQ 
values typical of high spin (HS) FeIII state (S=5/2), whereas 
the second one has δ and ΔEQ values in the range of the 
quantum mechanical admixed spin (QS) state (S=3/2, 
5/2).17 
A coordination complex having a quantum mechanical 
mixture of spin states corresponds to a single magnetic 
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species with magnetic properties distinct from pure spin 
species. This is different from a thermal mixtures of spin 
states in which molecules can be monitored in two 
magnetically distinguishable pure spin states. This mixing 
of spin states, although allowed by the selection rules, will 
only occur if the energy separation between unperturbed 
pure spin states is comparable or less than the spin-orbit 
coupling constant (about 300 cm-1 in ferric heme 
complexes).18 
Figure 60 Iron (III) spin states. 
Increasing the temperature from 6 to 80K, and even up to 
200K, there is an unexpected broadening of the signals 
(Figure 56-59, Table 13) for both isomers. Such broadening 
has been reported in literature as evidence of a 
temperature-dependent dynamic reorientation of ligands.19 
Further experiments are needed, to determine which kind 
of dynamic behavior we are observing.  
Mössbauer spectra have been also collected in 
phosphate buffer 50 mM pH 6.5, 50% TFE (v/v), at T = 6K 
(Figure 61-62, Table 14). 
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Figure 61 Mössbauer spectrum of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 (3.6∙10-3 M) in phosphate buffer 50 mM pH 6.5, 50% TFE 
(v/v). 
 
Figure 62 Mössbauer spectrum of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2 (4.7∙10-3 M) in phosphate buffer 50 mM pH 6.5, 50% TFE 
(v/v). 
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Table 14 Isomer shift (δ), quadrupole splitting (ΔEQ), full width half 
maximum (FWHM) and relative intensity of the two observed species 
in the Mössbauer spectra of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 
1 and 2 in phosphate buffer 50 mM pH 6.5, 50% TFE (v/v) at T= 6K. 
 
The spectra show two species in about 80:20 ratio for both 
isomers. These species have been identified, respectively, 
as HS and QS configurations. Therefore, we find the same 
spin states in solid state and in solution, but in a different 
ratio. With a more precise analysis, we notice that the ΔEQ 
values of the QS configurations for both isomers are quite 
different in solution and in solid state. For the isomer 1 
such parameter is 2.64 mm s-1, whereas larger quadrupole 
splitting values (ΔEQ =2.8-3.5 mm s-1) are expected for the 
QS state. This could mean a higher 5/2 than 3/2 spin state 
character in the QS configuration. 
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2.3.5  Spin state: EPR spectroscopy 
The characterization of the most active complexes 
by EPR spectroscopy was performed in collaboration with 
Prof. Marina Bennati Group at the Max Planck Institute for 
Biophysical Chemistry in Göttingen (Germany). 
To make a comparison with Mössbauer results, 
first of all EPR spectra have been collected on both isomers 
in solid state (lyophilized from acid conditions), at T = 4K 
(Figure 63). Other temperatures (20K, 70K) have been 
explored, but the spectra show the same signals, but lower 
in intensity (data not shown).  
 
Figure 63 EPR spectra of FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 
(purple) and 2 (orange) in solid state at T = 4K: frequency, 9.41 GHz; 
power, 0.1002 mW; sweep width, 5000 G; center field, 2500 G;  
attenuation, 33 dB; 2564 pt; 3 scans. 
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The EPR spectra of the two enzymes in solid states at           
T = 4K are almost identical, and show three signals with g = 
5.63, 3.60, 2.00 (mean g⊥ ≈ 4.61). Generally, for a ferric HS 
state a pattern of EPR signals with g⊥ ≈ 6, g// ≈ 2 is expected, 
whereas for the ferric QS state a pattern with 4 < g⊥ < 6,    
g// ≈ 2 is mostly reported. However, there are in literature 
some examples of HS and QS states with g⊥-value lower 
than 6 and 4, respectively. 20–22  
By double integrating the EPR spectra, it is possible to 
compare the intensities of the EPR signals. The ratio of         
g = 5.63 to g = 2.00 signals is almost half than that expected 
for a HS species; this suggests that the g = 2.00 signal 
origins from two signals. Moreover, the intensities of the     
g = 5.63 and g = 3.60 signals are almost identical, and 
therefore, taking account of Mössbauer experiments also, 
the EPR spectra have to be interpreted as a superposition 
of HS and QS states. Finally, barley peroxidase displays a 
pattern of EPR signals (g = 5.36, 3.75, 1.93; mean g⊥ ≈ 4.56) 
with g-values very similar to those of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 and 2, that was related to the 
presence of HS and QS states,20 strengthening our 
assignment. 
The spin states pH dependence has been explored 
by acquiring EPR spectra on both isomers in phosphate 
buffer 50 mM, 50% TFE (v/v) at different pH. 
In Figure 64, the EPR spectra of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 and 2 at different pH at T = 4K 
are reported. EPR spectra of the two isomers at higher 
temperatures (T= 20K, 70K) have been acquired: they 
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display the same signals, but lower in intensity than at T= 
4K (data not shown).  
 
 
 
 
 
 
 
 
 
 
Figure 64 EPR spectra (T= 4K) of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 (7.6∙10-5 M) and 2 (9.2∙10-5 M) in phosphate buffer 50 mM, 
50% TFE (v/v), at different pH: frequency, 9.41 GHz; power, 0.1002 
mW; sweep width, 5000 G; center field, 2500 G;  attenuation, 33 dB; 
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2564 pt; 3 scans. The spectra of the isomer 1 have been blank 
subtracted.  *cavity signal 
For both isomers, the line with g = 3.60 (Figure 63) almost 
disappears in solution at all investigated pHs. The patterns 
of EPR signals shown in Figure 64 are very similar, and 
should be attributed to a superposition of HS and QS 
configurations; the g⊥-values are higher than 5.5, indicating 
an higher content of HS than QS state at all investigated 
pHs, confirming the Mössbauer results in solution. 
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2.4 Preliminary structural analysis: 
NMR and CD spectroscopies on 
Co(III) derivatives 
With the aim of structurally characterize the new 
compounds, the diamagnetic CoIII ion was inserted into 
Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 apo forms, by 
using CoII-acetate, according to the literature method.23 
The RP-HPLC profile (Figure 65) of the reaction 
mixture for the isomer 2 revealed the presence of two 
equally abundant species. A similar behavior was observed 
for the isomer 1. These species were separated by 
preparative RP-HPLC. The ESI-MS analysis reveals that they 
have the same molecular weight (Figure 66-67); the UV-Vis 
spectra are almost identical (Figure 68) and are 
characteristic of a CoIII-porphyrin complex with a mono-His 
axial coordination. 
 
 
Figure 65 RP-HPLC profile of CoIII-Lys9Dab(D)-Mimochrome VIa 
isomer 2.  
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Figure 66 ESI-MS spectrum of pure CoIII-2Aib1Dab-MimoVI isomer 2, 
2a species. The mass spectrum was in agreement with the expected 
mass (calculated mass: 3466.46 Da; experimental mass: 3465.6 ± 0.7 
Da). 
 
Figure 67 ESI-MS spectrum of pure CoIII-2Aib1Dab-MimoVI isomer 2, 
2b species. The mass spectrum was in agreement with the expected 
mass (calculated mass: 3466.46 Da; experimental mass: 3465.7 ± 0.8 
Da). 
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Figure 68 Overlap of the UV-Vis spectra of the two species. 
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As a preliminary characterization, the species derived from 
the isomer 2, named 2a and 2b, were individually analyzed 
by Nuclear Magnetic Resonance (NMR) and CD 
spectroscopies, in H2O/TFE 60/40 (v/v). 
 1H NMR spectra in the low and high field regions are 
reported in Figure 69; the spectrum of CoIII-Mimochrome VI 
is also shown for comparison. 
 
 
Figure 69 1H NMR spectra of CoIII-Lys9Dab(D)-Mimochrome VIa 2a 
and 2b in the high field (top) and low field (bottom) regions compared 
to that of CoIII-Mimochrome VI.  
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The signals showed in Figure 69 (top) were unequivocally 
assigned to the δ- and ε-CH imidazole protons of the 
coordinating histidine, that experience an extremely large 
ring current effect and therefore appear in the high field 
region of the spectrum. 
The signals in the low field region (Figure 69, bottom) were 
identified as the four meso CH protons (5H, 10H, 15H, 20H), 
the two pyrrolic NH protons (8H, 13H) and the imidazole δ-
NH proton of the coordinating histidine. 
Only one set of resonances for the deuteroporphyrin 
protons was observed, in contrast to the 1H NMR spectrum 
of the prototype, CoIII-Mimochrome VI, which displays a 
more complex spectrum indicative of the presence of 
multiple species in solution. 
The CD spectra in the Soret region of CoIII-
Lys9Dab(D)-Mimochrome VIa 2a and 2b in the same 
conditions of the NMR experiment (H2O/TFE 60/40, v/v), 
are reported in Figure 70. 
The 2a species displays a strong negative induced Cotton 
effect, centred at 408 nm, whereas the 2b species displays a 
strong positive induced Cotton effect, centred at 409 nm. 
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Figure 70 CD spectra in the Soret region of CoIII-Lys9Dab(D)-
Mimochrome VIa 2a (1.4∙10-5 M) and 2b (2.4∙10-5 M) in H2O/TFE 60/40 
(v/v).  
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2.5 Discussion 
The new developed Mimochrome VIa generation 
has been designed with the aim of stabilizing the three-
dimensional sandwich structure, typical of Mimochromes, 
while preserving or enhancing functionality. The 
introduction of Aib residues on the decapeptide chain 
allowed the identification and separation of two 
regioisomers for each new analogue, demonstrating the 
role of Aib residues as structural constraints. 
The functional characterization proved that all the 
new analogues posses increased peroxidase-like activity 
and stability toward bleaching, with respect to the 
prototype, FeIII-Mimochrome VI, and FeIII-Mimochrome VI 
first generation of analogues (Figure 71).  
Among the new Mimochromes, the highest T.O.N. (10·103) 
was found for Mimochrome VIa and Lys9Dab(D)-
Mimochrome VIa isomers 2, whose deuteroporphyrin-
decapeptide linker contain, respectively, four and two 
methylenic groups; a lower T.O.N. (8.3·103) was found for 
Lys9Orn(D)-Mimochrome VIa isomers 1 and 2 (three 
methylenic groups in the deuteroporphyrin-decapeptide 
linker), suggesting the presence of an even-odd effect. 
Moreover, Mimochrome VIa and Lys9Dab(D)-Mimochrome 
VIa isomers 2 display a slightly higher T.O.N. (10·103) with 
respect to the isomers 1 (9.1·103), suggesting that the 
methyl positions on the deuteroporphyrin respect to the 
peptide chain influence the stability. 
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Figure 71 Catalytic constants and T.O.N.s of: FeIII-Mimochrome VI, FeIII-
E2L(TD)-Mimochrome VI (the best catalyst of the first generation of 
Mimochrome VI analogues), and all the new developed Mimochromes. 
Error bars are reported. (a) Data from reference 6. (b) Data from 
reference 1. 
The decrease in the deuteroporphyrin-decapeptide linker 
length is accompanied by an increase in the apparent 
catalytic constant (Figure 71). This result confirmed the 
correctness of the asymmetric Mimochrome design for 
catalytic purposes and highlight that this simple scaffold is 
well-suited for point amino acid substitutions. The catalytic 
constant of FeIII-Lys9Dab(D)-Mimochrome VIa isomers 1 
and 2 are 3-fold higher than that of FeIII-Mimochrome VI, 
and only 6-fold lower than that of HRP, the natural model of 
reference, under the experimental conditions for maximal 
activity of each enzyme. 
The pH-dependence reactivity of FeIII-Lys9Dab(D)-
Mimochrome VIa isomers 1 and 2 (Figure 35) is similar to 
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that found for FeIII-Mimochrome VI and its first generation 
of analogues.1,6 In all cases, data fitting of v0 vs. pH, 
according to model equation described elsewhere,6 gave 
pKa1 ≈ 5 and pKa2 ≈ 8, with the maximum activity at pH ≈ 
6.5. This indicates that at least two ionizable groups are 
involved in the modulation of the reactivity. In a previous 
publication,1 we proposed that the first transition is due to 
the deprotonation of the Glu2 on the decapeptide chain, 
which then could ion-pair with the Arg10 on the 
tetradecapeptide chain, stabilizing the sandwich structure 
and positively influence the catalytic properties. The 
decreasing activity to increasing pHs from 6.5 to 8.0, can be 
attributed to an higher molar fraction of the enzyme 
complex in the His/OH- iron axial coordination form. In fact, 
the optical transition observed in the UV/Vis pH titration 
with midpoint at pH ≈ 7 for both isomers, has been 
attributed to a ligand exchange from water to the harder 
hydroxide ion (Figure 36-37). This ligand exchange, 
occurring at the distal site above pH 6.5, interferes with the 
H2O2 binding and catalysis triggering, causing a decrease in 
efficiency. 
UV-Vis pH titration data of FeIII-Lys9Dab(D)-Mimochrome 
VIa isomer 2 were used to describe the three pH-dependent 
species (Figure 72). At pH 3.0, the mainly HS H2O/H2O iron 
axial coordination species is predominant. A second species 
is also present at about 12%, reaching the maximum 
concentration at pH 5.4. It corresponds to a predominantly 
HS His-H2O iron axial coordination form. Increasing the pH, 
another species appears, in which the harder hydroxide 
ligand, in place of the water molecule, binds the ferric ion. 
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At pH 6.5, the molar fraction of the active form (His/H2O) is 
68%, whereas the contribution of the H2O/H2O form is 
negligible (<0.2%).  
Although the first transition of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 cannot be determined, we 
presume that it most likely happens at pH lower than 4 
(Figure 36). Thus, we can deduce that the contribution of 
the possible H2O/H2O form is, also in this case, negligible. 
Therefore, the molar fraction of the active form (His/H2O) 
at pH 6.5 for the isomer is 72%; this higher value could 
explain the slight difference in the apparent catalytic 
constants values between the two isomers. 
 
Figure 72 Speciation curves as a function of pH of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 2 (data from UV-Vis pH titration in Figure 37). 
All Mimochromes showed their peptide secondary 
structure strictly related to the presence of the co-solvent 
TFE.6,24–27 In particular, the TFE-dependent peptides 
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structure of FeIII-Mimochrome VI was nicely correlated to 
its catalytic performances, thus demonstrating that the 
correct folding of both chains is essential for reactivity.6 
The α-helix content of FeIII-Lys9Dab(D)-Mimochrome VIa 
isomers 1 and 2 increases in the presence of TFE, as shown 
by far-UV CD data (Figure 38-46). The α-helix conformation 
is reached upon addition of ≈ 30% TFE (v/v) at all 
investigated pHs.  
In the Soret region, at pH 5.0 a negative induced 
Cotton effect was found in the CD spectra (Figure 47, 52) 
for both isomers. At pH 6.5 and without the co-solvent TFE, 
an overall S-shaped CD spectrum was observed for both 
isomers (Figure 48, 53). At pH 9.0 a very weak Cotton effect 
was found for both isomers.   
Molecules characterized by enantiomeric orientations of 
the peptide chains with respect to the deuteroporphyrin 
ring may induce opposite-sign Cotton effects into the Soret 
region.  
It has been widely reported that the protein folding around 
the heme chromophore is the main factor inducing optical 
activity in the Soret transition for heme-protein.28 Because 
of the mutual orientation of the heme and the protein, an 
induced Cotton effect may result from a coupling of π-π* 
heme transition with π-π* and n-π* transitions localized in 
the polypeptide backbone or π- π* transitions of aromatic 
sidechains. 
Theoretical studies have shown that the shape of the heme 
π-π* Cotton effects depends upon the direction of 
polarization of the Soret components in the heme plane. 
However, the shape and the complexity of the Soret-Cotton 
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effect cannot be easily related to the protein conformation 
and structural organization.24 
The splitting into two opposite bands of the CD Soret band 
(S-shaped) that appears for both isomers at pH 6.5 and 9.0 
can be related to the presence of two isomers. Different 
positions of the maxima, different shapes, and different 
intensities in the Soret-region Cotton effect of the 
diastereomeric forms may give an overall S-shaped 
spectrum. Further, the S-shaped spectrum can also be 
characteristic of exciton splitting resulting from heme- 
heme interaction.28 
CD in the far-UV region proved that the α-helix content in 
both isomers increases in the presence of TFE; CD in the 
Soret region proved that the induced Cotton effect also 
increases at increasing TFE content (Figure 47-55), 
suggesting that the stabilization of the secondary structure 
facilitates inter-chains and peptide-heme interactions. This 
mutual correlation between the secondary and the tertiary 
structure has been investigated (Figure 73).  
 
Figure 73 Plot of [θ]222 as function of [θ]386.4 at different TFE 
concentrations (%, v/v) at pH 5.0 and 6.5 for FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1. []386.4 is reported as molar ellipticity, 
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whereas []222 as mean residue ellipticity. Tags refer to the TFE 
concentration (%, v/v). 
Two different slopes in the range 0-20% and 20-50% TFE 
(v/v) were observed at pH 5.0 and pH 6.5 for both isomers 
(data of isomer 1 in Figure 73, as an example), indicating 
the occurrence of two different phenomena. With the 
assumption that the induced Cotton effect may result from 
a coupling of π-π* heme transition with n-π* and π-π* 
transitions of the polypeptide backbone, it is reasonable to 
hypothesize that the increase in intensity of the Soret-
induced Cotton effect at TFE concentration up to 20% is 
related to the increase in helical content (Figure 73). At TFE 
concentrations higher than 20%, the helical content slightly 
increases, whereas the intensity of the induced Cotton 
effect largely increases. This confirmed the effectiveness of 
the inter-helical interactions in reinforcing the sandwich 
structure and in driving the peptide chains to fold into a 
unique topology around the heme. 
Mössbauer and EPR results in solid state (Figure 
56-57 and 63, Table 13) and in solution (Figure 61-62 and 
64, Table 14) show that FeIII-Lys9Dab(D)-Mimochrome VIa 
isomer 1 and 2 a mixture of two spin states: high spin 
(S=5/2) and quantum-mechanical admixed spin (S=3/2, 
5/2). These two spin state are in 1:1 ratio in solid state, 
whereas a predominant HS state was found in solution. 
The QS state is very rare in nature, and is a distinctive 
characteristic of the class III heme peroxidases of the plant 
peroxidase superfamily.29 Among them, it has been only 
observed, mixed with other spin state species, in 
Horseradish Peroxidase A1, A2, C,30 in Soybean 
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Peroxidase31 and in Barely Peroxidase.32 HRP C samples, at 
physiological pH, are mixtures of QS and HS states, with 
relative populations dependent upon the particular 
purification procedure used; in situ, HRP C has roughly 
equal proportions of QS and HS configurations.18 Therefore, 
UV-Vis, and Mössbauer and EPR results proved that the 
iron (III) coordination environment of FeIII-Lys9Dab(D)-
Mimochrome VIa isomer 1 and 2 is similar to that of the 
Horseradish Peroxidase, our natural model of reference, 
confirming the correctness of the design. 
The proton NMR spectra of CoIII-Lys9Dab(D)-
Mimochrome VIa 2a and 2b reveal the presence of one 
deuteroporphyrin species, in contrast to what observed in 
the proton NMR spectrum of the prototype, CoIII-
Mimochrome VI (Figure 69). This result lays the basis for 
the complete structural determination by NMR. Moreover, 
CD spectra of CoIII-Lys9Dab(D)-Mimochrome VIa 2a and 2b 
display, respectively, strong negative and positive induced 
Cotton effects, both centred at ≈ 409 nm (Figure 70). In 
CoIII-Mimochrome I, the negative Cotton effect was 
attributed to the Δ isomer, whereas the positive Cotton 
effect to the Λ isomer;25 this suggests that CoIII-Lys9Dab(D)-
Mimochrome VIa 2a and 2b could also correspond, 
respectively, to the Δ and Λ isomers. If the structural 
determination confirmed our hypothesis, this would be the 
first isolation of the Δ and Λ isomers in a penta-coordinated 
complex. 
 
 
 
Chapter II: Results and discussion 
- 136 - 
 
References 
(1)  Vitale, R.; Lista, L.; Cerrone, C.; Caserta, G.; Chino, M.; Maglio, O.; 
Nastri, F.; Pavone, V.; Lombardi, A. Org Biomol Chem 2015. 
DOI:10.1039/c5ob00257e 
(2)  Schweitzer-Stenner, R.; Gonzales, W.; Bourne, G. T.; Feng, J. A.; 
Marshall, G. R. J. Am. Chem. Soc. 2007, 129 (43), 13095–13109. 
(3)  Improta, R.; Rega, N.; Aleman, C.; Barone, V. Macromolecules 
2001, 34 (21), 7550–7557. 
(4)  Karle, I. L.; Balaram, P. Biochemistry (Mosc.) 1990, 29 (29), 
6747–6756. 
(5)  Rohl, C. A.; Doig, A. J. Protein Sci. 1996, 5 (8), 1687–1696. 
(6)  Nastri, F.; Lista, L.; Ringhieri, P.; Vitale, R.; Faiella, M.; Andreozzi, 
C.; Travascio, P.; Maglio, O.; Lombardi, A.; Pavone, V. Chem. - Eur. 
J. 2011, 17 (16), 4444–4453. 
(7)  Childs, R. E.; Bardsley, W. G. Biochem. J. 1975, 145 (1), 93–103. 
(8)  Rodriguez-Lopez, J. N.; Smith, A. T.; Thorneley, R. N. J. Biol. Chem. 
1996, 271 (8), 4023–4030. 
(9)  Munro, O. Q.; Marques, H. M. Inorg. Chem. 1996, 35 (13), 3752–
3767. 
(10)  Yonetani, T.; Anni, H. J. Biol. Chem. 1987, 262 (20), 9547–9554. 
(11)  Feis, A.; Marzocchi, M. P.; Paoli, M.; Smulevich, G. Biochemistry 
(Mosc.) 1994, 33 (15), 4577–4583. 
(12)  Urry, D. W.; Pettegrew, J. W. J. Am. Chem. Soc. 1967, 89 (20), 
5276–5283. 
(13)  Goodman, M.; Listowsky, I.; Masuda, Y.; Boardman, F. 
Biopolymers 1963, 1 (1), 33–42. 
(14)  Nelson, J. W.; Kallenbach, N. R. Proteins Struct. Funct. Bioinforma. 
1986, 1 (3), 211–217. 
(15)  Jasanoff, A.; Fersht, A. R. Biochemistry (Mosc.) 1994, 33 (8), 
2129–2135. 
(16)  Greenfield, N. J.; Fasman, G. D. Biochemistry (Mosc.) 1969, 8 (10), 
4108–4116. 
(17)  Debrunner, P. G.; Lever, A. B. P.; Gray, H. B. Phys. Bioinorg. Chem. 
Ser. VCH 1989. 
(18)  Maltempo, M. M.; Moss, T. H. Q. Rev. Biophys. 1976, 9 (02), 181–
215. 
(19)  Burger, B.; Demeshko, S.; Bill, E.; Dechert, S.; Meyer, F. Angew. 
Chem. Int. Ed. 2012, 51 (40), 10045–10049. 
(20)  Howes, B. D.; Schiodt, C. B.; Welinder, K. G.; Marzocchi, M. P.; Ma, 
J. G.; Zhang, J.; Shelnutt, J. A.; Smulevich, G. Biophys. J. 1999, 77 
(1), 478–492. 
 
Chapter II: Results and discussion 
- 137 - 
 
(21)  Chouchane, S.; Girotto, S.; Kapetanaki, S.; Schelvis, J. P.; Yu, S.; 
Magliozzo, R. S. J. Biol. Chem. 2003, 278 (10), 8154–8162. 
(22)  Kintner, E. T.; Dawson, J. H. Inorg. Chem. 1991, 30 (26), 4892–
4897. 
(23)  Buchler, J.W.,. In The Porphyrins, Volume 1; David Dolphin, Series 
Ed.; NY, USA, 1979; Vol. I, pp 389–483. 
(24)  Nastri, F.; Lombardi, A.; Morelli, G.; Maglio, O.; D’Auria, G.; 
Pedone, C.; Pavone, V. Chem. - Eur. J. 1997, 3 (3), 340–349. 
(25)  D’Auria, G.; Maglio, O.; Nastri, F.; Lombardi, A.; Mazzeo, M.; 
Morelli, G.; Paolillo, L.; Pedone, C.; Pavone, V. Chem. - Eur. J. 
1997, 3 (3), 350–362. 
(26)  Lombardi, A.; Nastri, F.; Sanseverino, M.; Maglio, O.; Pedone, C.; 
Pavone, V. Inorganica Chim. Acta 1998, 275-276, 301–313. 
(27)  Costanzo, L.; Geremia, S.; Randaccio, L.; Nastri, F.; Maglio, O.; 
Lombardi, A.; Pavone, V. JBIC J. Biol. Inorg. Chem. 2004, 9 (8), 
1017–1027. 
(28)  Myer, Y. P. Methods Enzymol. 1978, 54, 249–284. 
(29)  Indiani, C.; Feis, A.; Howes, B. D.; Marzocchi, M. P.; Smulevich, G. 
J. Am. Chem. Soc. 2000, 122 (30), 7368–7376. 
(30)  Feis, A.; Howes, B. D.; Indiani, C.; Smulevich, G. J. Raman 
Spectrosc. 1998, 29 (10-11), 933–938. 
(31)  Nissum, M.; Feis, A.; Smulevich, G. Biospectroscopy 1998, 4 (6), 
355–364. 
(32)  Indiani, C.; Feis, A.; Howes, B. D.; Marzocchi, M. P.; Smulevich, G. 
J. Inorg. Biochem. 2000, 79 (1-4), 269–274. 
 
  
 
 
Chapter III  
Conclusions 
 
Chapter III: Conclusions 
- 139 - 
 
Conclusions 
The research project here reported is focused on 
the rational design, synthesis, and characterization of a new 
class of mini-enzymes. These compounds belong to a family 
of covalent heme-peptide models developed by                   
the Artificial Metallo-Enzyme Group of Naples: 
Mimochromes.1–8 Over the years, several models have been 
developed, up to FeIII-Mimochrome VI,7 a penta-
coordinated complex which catalyzes the oxidation of 
reducing substrates by activating the “clean” oxidant 
hydrogen peroxide. The molecular scaffold of FeIII-
Mimochrome VI was used to introduce point substitutions 
in the peptide sequences in order to stabilize a unique 
species with improved catalytic functionality. 
These substitutions were introduced on the decapeptide 
chain, since it most likely experiences the higher 
conformational freedom, due to the lack of the coordinating 
histidine, that firmly anchors the tetradecapeptide chain on 
the heme. The Aib, a natural, non-coded amino acid, with a 
very high helical propensity,9,10 was introduced in 3 and 7 
positions of the decapeptide chain, obtaining a new 
molecule, named Mimochrome VIa. In the next stage of 
design, a systematic evaluation of the linker length between 
the porphyrin and the decapeptide chain was carried out. 
To further stabilize the sandwich structure, the linker 
length was progressively decreased: Lys at position 9 was 
substituted with Orn and with Dab, whose side chains 
contain, respectively, one and two methylenic group less 
than lysine side chain. Thus, two new molecules were 
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obtained, named, respectively, Lys9Orn(D)-Mimochrome 
VIa and Lys9Dab(D)-Mimochrome VIa.  
The Aib introduction allowed to separate two regioisomers 
for each compound, due to the coupling of the decapeptide 
to the propionic group at 2 position and of the 
tetradecapeptide at 18 position of the deuteroporphyrin, 
and vice versa. These two regioisomers, named isomer 1 
and 2, were isolated and the metal was individually 
inserted into these two species. 
The functional screening of the new class of 
Mimochromes highlighted that: 
   introducing Aib residues increases the stability 
toward bleaching, as shown by the higher turnover 
number; 
  decreasing the decapeptide-porphyrin linker length 
increases the catalytic activity. 
Therefore, FeIII-Lys9Dab(D)-Mimochrome VIa isomer 1 and 
2 have been selected as the best enzymes, in terms of 
catalytic activities and turnover number. While being more 
than tenfold smaller in terms of molecular weight, FeIII-
Lys9Dab(D)-Mimochrome VIa isomer 1 and 2 display 
improved enzyme-like properties, that in turn approach 
HRP, the natural parent enzyme. 
The maximum activity of the new Aib-containing 
Mimochromes is at about neutral pH (6.5), and this 
represents an important outcome, since the maximum 
activity of HRP is at acidic pH (4.6). It should be outlined 
that pH 6.5 does not represent the optimal pH for the 
presence of the catalytically active His-H2O species (molar 
fraction 72% for the isomer 1 and 68% for the isomer 2 at 
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pH 6.5). Considering that the two isomers of FeIII-
Lys9Dab(D)-Mimochrome VIa lack a residue in the active 
site able to assist the hydrogen peroxide deprotonation 
similar to His42 in HRP,11–13 pH 6.5 could represent a 
compromise, which simultaneously ensures the highest 
amount of His-H2O coordination state and hydrogen 
peroxide deprotonation. 
UV-Vis, CD, EPR and Mössbauer spectroscopies 
were used in combination to gain insight into the molecular 
basis of the catalytic improvement, correlating the primary, 
secondary and tertiary structures of the new mini-enzymes 
with the spin state of the metal ion and the nature of the 
axial ligands. It was demonstrated that the iron(III) 
coordination environment is similar to that of the 
Horseradish Peroxidase, the natural parent enzyme. 
NMR spectroscopy on the cobalt (III) complex of 
Lys9Dab(D)-Mimochrome VIa isomer 2 proved that the 
improvement in the catalytic properties is accompanied by 
an improvement in the structural properties, since its NMR 
spectrum displays a unique species, in contrast with the 
NMR spectrum of  the prototype, CoIII-Mimochrome VI, 
which displays a more complex spectrum indicative of the 
presence of multiple species in solution. The complete 
structural determination by NMR of CoIII- Lys9Dab(D)-
Mimochrome VIa isomer 2 is in progress. 
Collectively, the results allow us to point out that 
Mimochromes scaffold holds essential elements to finely 
tune the reactivity. This represents a very important 
checkpoint for the rational design of new and improved 
bio-mimetic catalysts, tailored for specific applications. 
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Further design, based on the results herein reported, will 
be aimed to: (i) favour the His-H2O species over a wider pH 
range; (ii) introduce amino acid residues assisting the acid–
base catalytic cleavage of the O–O bond, as His42 acts in 
HRP.11–13 
Recently, an intriguing biotechnological application 
of the heme-protein model here described has been 
explored. On the basis of its high peroxidase-like catalytic 
activity and its small dimensions (3.5 kDa) compared to 
natural protein, FeIII-Lys9Dab(D)-Mimochrome VIa has 
been proposed as reporter enzyme in Enzyme-linked 
immunosorbent assays (ELISA). The ELISA test relies on 
immunocomplex formation, between an antigen and a 
specific antibody. The detector system is an enzyme (HRP 
often)12 covalently bound to the antibody; a colorimetric 
signal from the enzymatic reaction allows to quantify 
immunocomplexes. The ELISA test has the advantage of 
being very simple and cheap, but sometimes it is little 
sensitive, with a high number of false-positives. The 
replacement of the natural HRP with the mini heme-
enzyme here described, has allowed to considerably 
increase the conjugation ratio enzyme/antibody. This 
should allow us to develop devices with a high sensitivity 
detection of analytes in samples of different nature, even at 
low concentrations, offering economic benefits and high 
performance.  
This project was proposed in “InKidia” business idea and 
received one of the first two Tech Hub 2015 prizes, for the 
foundation of new Start Up Companies. 
 
Chapter III: Conclusions 
- 143 - 
 
References 
(1)  Nastri, F.; Lombardi, A.; Morelli, G.; Maglio, O.; D’Auria, G.; 
Pedone, C.; Pavone, V. Chem. - Eur. J. 1997, 3 (3), 340–349. 
(2)  D’Auria, G.; Maglio, O.; Nastri, F.; Lombardi, A.; Mazzeo, M.; 
Morelli, G.; Paolillo, L.; Pedone, C.; Pavone, V. Chem. - Eur. J. 
1997, 3 (3), 350–362. 
(3)  Lombardi, A.; Nastri, F.; Pavone, V. Chem. Rev. 2001, 101 (10), 
3165–3189. 
(4)  Geremia, S.; Di Costanzo, L.; Randaccio, L.; Lombardi, A.; Pavone, 
V.; Campagnolo, M. Acta Cryst 2002, 58, C277. 
(5)  Costanzo, L.; Geremia, S.; Randaccio, L.; Nastri, F.; Maglio, O.; 
Lombardi, A.; Pavone, V. JBIC J. Biol. Inorg. Chem. 2004, 9 (8), 
1017–1027. 
(6)  Lombardi, A.; Nastri, F.; Marasco, D.; Maglio, O.; De Sanctis, G.; 
Sinibaldi, F.; Santucci, R.; Coletta, M.; Pavone, V. Chem. - Eur. J. 
2003, 9 (22), 5643–5654. 
(7)  Nastri, F.; Lista, L.; Ringhieri, P.; Vitale, R.; Faiella, M.; Andreozzi, 
C.; Travascio, P.; Maglio, O.; Lombardi, A.; Pavone, V. Chem. - Eur. 
J. 2011, 17 (16), 4444–4453. 
(8)  Vitale, R.; Lista, L.; Cerrone, C.; Caserta, G.; Chino, M.; Maglio, O.; 
Nastri, F.; Pavone, V.; Lombardi, A. Org Biomol Chem 2015. 
DOI:10.1039/c5ob00257e 
(9)  Schweitzer-Stenner, R.; Gonzales, W.; Bourne, G. T.; Feng, J. A.; 
Marshall, G. R. J. Am. Chem. Soc. 2007, 129 (43), 13095–13109. 
(10)  Improta, R.; Rega, N.; Aleman, C.; Barone, V. Macromolecules 
2001, 34 (21), 7550–7557. 
(11)  Poulos, T. L.; Kraut, J. J. Biol. Chem. 1980, 255 (17), 8199–8205. 
(12)  Azevedo, A. M.; Martins, V. C.; Prazeres, D. M. F.; Vojinović, V.; 
Cabral, J. M. S.; Fonseca, L. P. In Biotechnology Annual Review; 
Elsevier, 2003; Vol. 9, pp 199–247. 
(13)  Veitch, N. C. Phytochemistry 2004, 65 (3), 249–259. 
 
 
 
 
 
Chapter IV  
Materials 
and Methods 
 
Chapter IV: Material and Methods 
 
- 145 - 
 
4.1 Materials 
Peptide synthesis was carried out using reagent 
grade anhydrous solvents. All the solvents adopted in the 
LC and LC-MS analysis, in the purifications, and in the 
solutions for the spectroscopic characterizations were 
HPLC or higher grade solvents, and were provided by 
Romil.  
Scavengers (EDT, TIS, TES) and TFE were supplied by 
Sigma Aldrich; TFA and DIEA were from Applied 
Biosystem; acetic anhydride was from Fluka and piperidine 
was from Merck. DMF, DCM, NMP, HFIP, ethanol and 
methanol were supplied by Romil. All reagents were used 
without further purification. 
The NovaSyn® TG Sieber resin  (substitution level 0.61 
mmol/g) and all the N-α-Fmoc amino acids were purchased 
from NovaBiochem; activating HOBt, HATU and PyBop 
were provided by LC Sciences, Anaspec and NovaBiochem, 
respectively.  
Deuteroporphyrin IX was from Porphyrin Products. Cobalt 
(II) acetate and iron (II) acetate were purchased from 
Sigma Aldrich.  
Precoated silica G-60 plates, F254, purchased from Merck, 
were used for thin-layer chromatography (TLC). 
Phosphate salts (monobasic and dibasic) for buffers 
preparation were provided by Fluka.  
Solvent mixtures are indicated in the respective sections.  
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4.2 Instrumentations 
Protected peptides were obtained by the use of ABI 
433 automatic peptide synthesizer.  
HPLC and LC-MS analysis were performed with a Shimadzu 
LC-10ADvp equipped with an SPDM10Avp diode-array 
detector. ESI-MS spectra were recorded on a Shimadzu LC-
MS-2010EV system with ESI interface, and Shimadzu LC-MS 
solution Workstation software for data processing. A Q-
array-octapole-quadrupole mass analyzer was used as 
detector. The optimized MS parameters were selected as 
followed: curved desolvation line (CDL) temperature 
250°C; block temperature 250°C; probe temperature 
250°C; detector gain 1.6 kV; probe voltage +4.5 kV; CDL 
voltage -15 V. Nitrogen served as nebulizer gas (flow rate: 
1.5 L·min-1).  
Preparative Flash Chromatography purifications were 
performed using a Biotage ISOLERA flash purification 
system, ISO-1SW model, equipped with a diode-array 
detector. 
Preparative HPLC purifications were performed with a 
Shimadzu LC-8A equipped with an SPD-10A detector. 
UV-Vis and CD analysis were performed on Cary Varian 50 
Probe UV Spectrophotometer and Jasco J-715 dichrograph, 
respectively. 
Mössbauer spectra were recorded using an alternating 
constant acceleration WissEL Mössbauer spectrometer 
consisting of a MR 360 Drive Unit, a MVT-1000 velocity 
transducer and a LND 45431 proportional counter 
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mounted on a LINOS precision bench. The Mössbauer 
system is equipped with a with a 57Co source in a Rh matrix 
with an initial activity of 1.85~GBq (kept at room 
temperature) and is operated in horizontal transmission 
geometry with source, absorber and detector in a linear 
arrangement. A Janis SHI 850 closed-cycle helium cryostat 
was used for low temperature measurements down to 6 K. 
Data acquisition was performed using a 512 channel 
analyzer. Isomer shifts are given relative to α-iron metal at 
ambient temperature. Simulation and evaluation of the 
experimental data was performed using the Mfit program 
(E. Bill, Max-Planck Institute for Bioinorganic Chemistry, 
Mülheim/Ruhr, Germany).  
EPR spectroscopic measurements were carried out using a 
Bruker Elexsys E500 CW-EPR and a Super-X microwave 
bridge operating at 9.3–9.5 GHz. The spectrometer was 
equipped with a standard Bruker X-band ER4119-SHQE 
cavity and a liquid helium cryostat (Oxford Instruments). 
NMR spectra were acquired at 298K on a Bruker Avance 
600 Spectrometer, equipped with a triple resonance cryo-
probe. Suppression of the water signal was accomplished 
by excitation sculpting sequence. 
The molecular graphics pictures were generated with 
PyMOL software (DeLano Scientific ltd)1 and VMD software 
(Visual Molecular Dynamics)2. 
Data analysis was made by using Origin Pro8 and 
Kaleidagraph softwares. 
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4.3 Solid-phase synthesis of 
peptides 
All protected peptides were synthesized by using 
an automatic peptide synthesizer (see instrumentations), 
with Fmoc strategy, on a 0.25 mmol scale, using a super 
acid labile resin, the NovaSyn® TG Sieber (substitution level 
0.61 mmol/g).  
The following four peptides were synthesized: 
- Tetradecapeptide (TD): Ac-Asp-Leu-Gln-Gln-Leu-
His-Ser-Gln-Lys-Arg-Lys-Ile-Thr-Leu-NH2; 
- Decapeptide (D): Ac-Asp-Glu-Aib-Gln-Leu-Ser-Aib-
Gln-Lys-Arg-NH2; 
- Lys9Orn(D): Ac-Asp-Glu-Aib-Gln-Leu-Ser-Aib-Gln-
Orn-Arg-NH2; 
- Lys9Dab(D): Ac-Asp-Glu-Aib-Gln-Leu-Ser-Aib-Gln-
Dab-Arg-NH2. 
For the synthesis of the peptides, the amino acids used are 
reported as follows: Fmoc-Asp(OtBu)-OH; Fmoc-Leu-OH; 
Fmoc-Gln(Trt)-OH; Fmoc-His(Trt)-OH; Fmoc-Ser(tBu)-OH; 
Fmoc-Lys(Mmt)-OH; Fmoc-Arg(Pbf)-OH; Fmoc-Lys(Boc)-
OH; Fmoc-Ile-(OH); Fmoc-Thr(tBu)-OH; Fmoc-Glu(OtBu)-
OH; Fmoc-Aib-OH; Fmoc-Orn(Mtt)-OH; Fmoc-Dab(Mtt)-OH.  
Once removed the Fmoc group from the resin, 
deprotection, coupling and capping steps were cyclically 
repeated with each amino acid, until the chain assembly 
was completed.3 At the end of the synthesis, the peptides, 
amidated at the C-termini, were finally acetylated at the N-
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termini with Ac2O/HOBt/DIEA solution in NMP.  
The steps performed in the synthetic procedure can be 
summarized as follows: 
1.  Deprotection: Fmoc group was removed with a 20% 
piperidine solution in NMP. After Fmoc deprotection, a 
NMP washing step was performed. 
2.  Activation: the carboxyl group of each Fmoc-amino acid 
was activated by direct addition in the cartridge of 1 
equivalent of PyBop. HATU was used for difficult 
couplings. 
3.  Coupling: the pre-activated Fmoc-amino acid reacted 
with the free amino-terminal group of the growing 
peptide chain on the resin in NMP. 
4.  Capping: this reaction was performed after each 
coupling step, using Ac2O/HOBt/DIEA solution in NMP. 
Capping cycle was introduced to prevent deletion 
byproducts. 
At completion of the synthesis, the resin was washed 
several times with DCM, NMP, isopropanol and methanol, 
and finally dried. 
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4.4 Mtt/Mmt deprotection and 
cleavage of the peptides 
   Mmt deprotection 
The N-ε Mmt protecting group of the Lys9 residue, 
in both tetradecapeptide and in one of the three 
decapeptide chains, was removed by repeated treatments 
(15 min, under gentle agitation) with a solution containing 
10% acetic acid and 20% TFE (v/v) in DCM. This procedure 
was repeated until no yellow colour, indicative of the 
presence of the (4-methoxyphenyl)diphenylmethyl cation, 
was detected in the eluent. Subsequently, in order to 
release the protected peptide from the resin, the resin was 
treated with 4 resin volumes of a freshly prepared cleavage 
mixture (1% TFA in DCM, v/v). The acidic mixture was 
incubated for 2 minutes, under mixing, and the solution 
was filtered with a vacuum pump, into an ice-cooled flask 
containing 1/5 acidic mixture volume of a freshly prepared 
basic solution (10% pyridine in methanol, v/v). The 
peptides elution was controlled by TLC analysis, by using as 
eluent the mixture chloroform/methanol 90/10 (v/v); each 
step was repeated until no product was detected in the 
collected fractions. The fractions containing the desired 
product were pooled and then evaporated under reduced 
pressure up to 5% of the volume. Ice-cold water was added 
and the mixture was cooled on ice to aid precipitation of 
the protected peptide. The product was washed several 
times, with fresh cold water and centrifuged at each step (4 
min at 4°C, at 3300 g). Then, it was dried under vacuum to 
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give the crude peptides. 
   Mtt deprotection 
In the two remaining decapeptide chains, Mtt 
protecting group of the Orn9 and Dab9 residues was 
removed by repeated treatments (1 hour, under gentle 
agitation) with a solution containing DCM:HFIP:TFE:TES 
65:20:10:5 (v/v). Every hour few resin beads were 
removed from the reaction mixture, and 1-2 drops of TFA 
were added. The (4-methylphenyl)diphenylmethyl cation 
produces a yellow color in TFA. Thus, this procedure was 
followed in order to verify the complete removal of the Mtt 
protecting group. The resin was then filtered, washed twice 
with DCM, DMF, 10% DIEA in DMF (v/v), DMF. 
Subsequently, in order to release the protected decapeptide 
from the resin, 4 resin volumes of a freshly prepared 
cleavage mixture (1% TFA, 3% TIS in DCM, v/v) were 
added. The acidic mixture was incubated for 2 minutes, 
under mixing, and the solution was filtered with a vacuum 
pump, into a flask containing 1/5 acidic mixture volumes of 
a freshly prepared basic solution (10% pyridine in 
methanol, v/v). The peptides elution was controlled by TLC 
analysis, by using as eluent the mixture 
chloroform/methanol 90/10 (v/v); each step was repeated 
until no product was detected in the collected fractions. The 
fractions containing the product were pooled and then 
evaporated under reduced pressure up to 5% of the 
volume. The protected peptide was extracted in 
chloroform/water three times, then the organic phase was 
anhydrified and dried under vacuum. The removal of Mtt-
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TIS adduct was obtained by washing the product with fresh 
diethyl ether and centrifuging at each step (4 min at 4°C, at 
3300 g). Therefore, it was dried under vacuum to give the 
crude C-terminal peptide amides. Orthogonal side chain 
protecting groups were found to be stable in conditions of 
Mmt and Mtt deprotection reaction and peptide cleavage 
reaction. 
The peptide homogeneity and identity were 
assessed by analytical RP-HPLC and by ESI mass 
spectrometry. A Vydac C18 column (4.6 mm·150 mm; 5 
μm), was used in the LC-MS analysis, eluted with H2O/0.1% 
TFA (v/v) (solvent A) and acetonitrile/0.1% TFA (v/v) 
(solvent B) linear gradient, from 50% to 90% B over 40 
min, at 0.5 mL·min-1 flow rate. 
Decapeptides and tetradecapeptide chromatograms and 
the relative mass spectra are reported in Figure 74-77. This 
first step of the work-up allowed to obtain peptides with     
≥ 90% purity level and with ≥ 80% yield. 
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Figure 74 RP-HPLC chromatogram of protected Mimochrome VIa 
decapeptide, Lys9 deprotected; ESI-MS spectrum of the peak at            
Rt= 41.31 min. One main chromatographic peak (λ = 210 nm) was 
detected and mass spectrum was in agreement with the expected mass 
(calculated mass: 2119.53 Da; experimental mass: 2119.4 ± 0.5 Da).  
 
 
[M-2Na+]/2 
[M-2H+]/2 
[M-H+-Na+]/2 
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Figure 75 RP-HPLC chromatogram of protected Mimochrome VIa 
Lys9Orn decapeptide, Orn9 deprotected; ESI-MS spectrum of the peak 
at Rt= 40.62 min. One main chromatographic peak (λ = 210 nm) was 
detected and mass spectrum was in agreement with expected mass 
(calculated mass: 2105.50 Da; experimental mass: 2105.2 ± 0.5 Da). MS 
analysis allowed to identify the minor peak (Rt= 53.44 min), as the fully 
protected peptide. 
[M-2H+]/2 
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Figure 76 RP-HPLC chromatogram of protected Mimochrome VIa 
Lys9Dab decapeptide, Dab9 deprotected; ESI-MS spectrum of the peak 
at Rt= 40.55 min. One main chromatographic peak (λ = 210 nm) was 
detected and mass spectrum was in agreement with the expected mass 
(calculated mass: 2091.48 Da; experimental mass: 2091.0 ± 0.5 Da). MS 
analysis allowed also to identify the minor peaks. At Rt= 36.53 min 
elutes the protected peptide, deprotected of Mtt group and lacking a Trt 
protecting group, maybe lost in the acidic elution conditions; the peak 
at Rt= 51.61 min corresponds to the fully protected peptide. 
[M-2H+]/2 
[M-Na+-H+]/2 
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Figure 77 RP-HPLC chromatogram of Mimochrome VIa protected 
tetradecapeptide, Lys9 deprotected; ESI-MS spectrum of the peak at Rt= 
54.31 min. One main chromatographic peak (λ = 210 nm) was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3239.12 Da; experimental mass: 3238.8 ± 0.5 Da). MS 
analysis allowed also to identify the minor peak. At Rt= 49.12 min 
elutes the protected peptide, deprotected of Mmt group, and lacking a 
Trt protecting group maybe lost in the acidic elution conditions. 
 
 
 
 
[M-3H+]/3 
[M-2H+]/2 
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4.5 Coupling of the decapeptide 
chains to the deuteroporphyrin 
After Mmt/Mtt deprotection, the decapeptide 
chains (D) were coupled to the deuteroporphyrin IX (DPIX). 
This reaction was performed in DMF, in presence of DIEA 
(7 eq.), HATU (1 eq.) and deuteroporphyrin IX*2HCl (1.5 
eq.) at peptide final concentration of 0.01 M. In order to 
avoid the formation of the undesired bi-substituted 
porphyrin (D-DPIX-D), this reaction was conducted by 
adding drop wise the peptide to the deuteroporphyrin (30 
adds every 2 minutes). The reaction mixture was stirred for 
2 h at room temperature, and the pH was assayed every 20 
min, and adjusted with DIEA (pH ≈ 8.0), if necessary. The 
reaction was monitored by analytical HPLC and by TLC 
(eluent: chloroform/methanol 90:10, Rf = 0.49). A Vydac C8 
column (4.6 mm·150 mm; 5 μm), was used in the HPLC 
analysis, eluted with H2O/0.1% TFA (v/v) (solvent A) and 
acetonitrile/0.1% TFA (v/v) (solvent B) linear gradient, 
from 50% to 90% B over 20 min, at 1.0 mL·min-1 flow rate.  
Two equally abundant peaks (1:1 ratio) were detected. 
Both peaks show the molecular mass expected for the 
desired mono-substituted Mimochrome VIa (D-DPIX). The 
analytical chromatograms reported in Figure 78-80, were 
recorded at λ = 210 nm (in magenta) and at λ = 400 nm (in 
blue). The peak eluted around 30 min corresponds to the 
undesired bi-substituted porphyrin (D-DPIX-D). The yield 
of this reaction, evaluated on the basis of the 
chromatographic peaks areas, was ≈ 80 %.  
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Figure 78 RP-HPLC chromatogram at the end of the coupling reaction 
of Mimochrome VIa mono-substituted derivative. The main 
chromatographic peaks (λ = 400 nm) correspond to the desired 
products (D-DPIX, two constitutional isomers). The minor peak         
(Rt= 30.65 min) corresponds to the undesired bi-substituted porphyrin 
(D-DPIX-D), whereas the excess of DPIX is eluted in the void volume. 
 
Figure 79 RP-HPLC chromatogram at the end of the coupling reaction 
of Lys9Orn(D)-Mimochrome VIa mono-substituted derivative. The 
main chromatographic peaks (λ = 400 nm) correspond to the desired 
products (Lys9Orn(D)-DPIX, two constitutional isomers). The minor 
peaks correspond to: the undesired bi-substituted porphyrin 
(Lys9Orn(D)-DPIX-Lys9Orn(D)), at Rt= 35.41 min, and the fully 
protected Lys9Orn decapeptide, at Rt= 25.12 min. The excess of DPIX is 
eluted in the void volume. 
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Figure 80 RP-HPLC chromatogram at the end of the coupling reaction 
of Lys9Dab(D)-Mimochrome VIa mono-substituted derivative. The 
main chromatographic peaks (λ = 400 nm) correspond to the desired 
products (Lys9Dab(D)-DPIX, two constitutional isomers). The minor 
peak, at Rt= 32.71 min, corresponds to the undesired bi-substituted 
porphyrin (Lys9Dab(D)-DPIX-Lys9Dab(D)), whereas the excess of DPIX 
is eluted in the void volume. 
The reaction mixture was evaporated under reduced 
pressure and dried. The crude products were purified by 
Flash Chromatography, on a SNAP HP 100 g silica column, 
using a chloroform/methanol gradient from 7 to 12% 
methanol over 6 column volumes, at 50 mL·min-1 flow rate. 
The products were eluted at 9% methanol, and obtained in 
a 83% yield. This purification allowed to remove all the 
excess of deuteroporphyrin IX, the undesired bi-substituted 
porphyrin (D-DPIX-D), and, if present, the fully protected 
decapeptide.  
 
 
 
Chapter IV: Material and Methods 
 
- 160 - 
 
4.6 Synthesis of Mimochrome VIa 
and its analogues apo forms  
The purified monopeptide D-DPIX derivative were 
used for the synthesis of the bi-substituted molecules. Each 
coupling reaction was conducted on the monopeptide 
derivative (1 eq.), in the presence of DIEA (6 eq.), HATU 
(1.2 eq.), and tetradecapeptide (1.1 eq.). The reaction 
mixture (8.5∙10-3 M in DMF) was incubated at room 
temperature for 2 h. The pH was checked during the 
reaction time and adjusted to ≈ 8, if necessary. The reaction 
progress was followed by TLC (eluent: 
chloroform/methanol 90:10, Rf = 0.65). At the end, the 
reaction mixture was evaporated under reduced pressure. 
The protected bi-substituted compounds were dissolved in 
chloroform and extracted with water three times. The 
organic phase was anhydrified with Na2SO4, evaporated 
under reduced pressure and dried. 
Finally, fully deprotected molecule was obtained by 
addition of the cleavage mixture (94% TFA, 2.5% EDT, 1% 
TIS, 2.5% H2O, v/v). The reaction was conducted under 
stirring, at 0°C for 1h and at room temperature for the 
second hour. The reaction mixture was concentrated on a 
rotary evaporator, the crude product precipitated by 
adding cold diethyl ether. The mixture was centrifuged 
(room temperature, at 3300 g), the supernatant was 
removed and the precipitate was washed twice with three 
volumes of cold diethyl ether. The crude product was dried, 
and then re-dissolved in water/0.1% TFA (v/v) and 
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analyzed by LC-MS. A Vydac C18 column (4.6 mm·150 mm; 
5 μm), was used in the LC-MS analyses, eluted with 
H2O/0.1% TFA (v/v) (solvent A) and acetonitrile/0.1% TFA 
(v/v) (solvent B) linear gradient, from 10% to 50% B over 
60 min, at 0.5 mL·min-1 flow rate.  
As already observed for the mono-substituted Mimochrome 
VIa derivatives, two peaks are present. They show the same 
mass spectra, corresponding to the desired Mimochrome 
VIa analogue. The analytical chromatogram and the mass 
spectrum of Lys9Dab(D)-Mimochrome VIa are reported in 
Figure 81-83, as an example. 
 
Figure 81 RP-HPLC chromatogram of Lys9Dab(D)-Mimochrome VIa 
apo form. 
Figure 82 ESI-MS spectrum of the peak at Rt= 53.02 min (calculated 
mass: 3409.78 Da; experimental mass: 3409.1 ± 0.8 Da). 
[M-3H+]/3 
[M-4H+]/3 
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Figure 83 ESI-MS spectrum of the peak at Rt= 53.34 min (calculated 
mass: 3409.78 Da; experimental mass: 3409.5 ± 0.4 Da). 
 
The crude material was then purified by preparative RP-
HPLC. A Vydac C18 column (50 mm·250 mm; 10 μm) was 
used, eluted with H2O/0.1% TFA (v/v) (solvent A) and 
acetonitrile/0.1% TFA (v/v) (solvent B) linear gradient, 
from 10% to 50% B over 50.1 min, at 100.0 mL·min-1 flow 
rate. This purification allowed to separate the two 
compounds for each apo form. 
The pooled fractions containing the desired products were 
lyophilized. 
 
 
 
 
 
[M-3H+]/3 
[M-4H+]/3 
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4.7 Iron insertion 
Iron ion was inserted, according to the acetate method 
procedure, slightly modified by us.4,5 Iron (II) acetate (10 
eq.) was added to a solution of pure Mimochrome VI 
analogue apo form (2.0∙10-4 M), in 2/3 TFE/AcOH (v/v), 
and the reaction mixture was kept at 50 °C for 2 h, refluxing 
under nitrogen. The reaction was monitored by analytical 
HPLC, using a Vydac C18 column, eluted with H2O/0.1% 
TFA (v/v) (solvent A) and acetonitrile/0.1% TFA (v/v) 
(solvent B) linear gradient, from 10% to 50% B over 30 
min, at 1.0 mL·min-1 flow rate. Once the reaction was 
completed, the solvent was removed under vacuum, and 
the products were purified, in order to remove the excess 
of iron acetate, by Reverse Phase-Flash Chromatography, 
on a SNAP KP-C18-HS 30 g column, using a gradient of 
acetonitrile in 0.1% aqueous TFA, 5% to 95% over 2 
column volumes, at 25 mL·min-1 flow rate. After 
lyophilisation, pure products were obtained as TFA salts. 
LC-MS analysis of all the synthesized compounds, 
confirmed their high purity (>95%) and the expected 
molecular weight (Figure 84-89). The analytical 
chromatograms were recorded at λ = 210 nm (in magenta) 
and at λ = 387 nm (in brown). A Vydac C18 column was 
used in the LC-MS analysis, eluted with H2O/0.1% TFA 
(v/v) (solvent A) and acetonitrile/ 0.1% TFA (v/v) (solvent 
B) linear gradient, from 10% to 50% B over 60 min, at 0.5 
mL·min-1 flow rate.  
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Figure 84 RP-HPLC chromatogram and ESI-MS spectrum of pure FeIII-
2Aib1Lys-MimoVI isomer 1. One chromatographic peak was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3491.66 Da; experimental mass: 3490.6 ± 1.2 Da). 
 
 
 
[M-4H+]/4 [M-3H+]/3 
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Figure 85 RP-HPLC chromatogram and ESI-MS spectrum of pure FeIII-
2Aib1Lys-MimoVI isomer 2. One chromatographic peak was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3491.66 Da; experimental mass: 3491.1 ± 1.0 Da). 
 
 
 
[M-4H+]/4 
[M-3H+]/3 
[M-2H+]/2 
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Figure 86 RP-HPLC chromatogram and ESI-MS spectrum of pure FeIII-
2Aib1Orn-MimoVI isomer 1. One chromatographic peak was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3477.63 Da; experimental mass: 3477.4 ± 0.4 Da). 
 
 
 
 
[M-4H+]/4 
[M-3H+]/3 
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Figure 87 RP-HPLC chromatogram and ESI-MS spectrum of pure FeIII-
2Aib1Orn-MimoVI isomer 2. One chromatographic peak was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3477.63 Da; experimental mass: 3477.0 ± 0.8 Da). 
 
 
 
 
[M-3H+]/3 
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Figure 88 RP-HPLC chromatogram and ESI-MS spectrum of pure FeIII-
2Aib1Dab-MimoVI isomer 1. One chromatographic peak was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3463.61 Da; experimental mass: 3463.3 ± 0.7 Da). 
 
 
[M-3H+]/3 
[M-4H+]/4 
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Figure 89 RP-HPLC chromatogram and ESI-MS spectrum of pure FeIII-
2Aib1Dab-MimoVI isomer 2. One chromatographic peak was detected 
and mass spectrum was in agreement with the expected mass 
(calculated mass: 3463.61 Da; experimental mass: 3463.3 ± 0.7 Da). 
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4.8 Cobalt insertion 
Cobalt ion (II) was inserted into 2Aib1Dab-MimoVI 
isomer 2 apo form, according to literature procedure.4 
Co(II) acetate (10 eq.) was added to a solution of pure apo 
form (2.0∙10-4 M), in 2/3 TFE/AcOH (v/v), and the reaction 
mixture was kept at 50 °C for 2 h, under reflux. The reaction 
was monitored by analytical HPLC. A Vydac C18 column 
(4.6 mm·150 mm; 5 μm), was used, eluted with H2O/0.1% 
TFA (v/v) (solvent A) and acetonitrile/0.1% TFA (v/v) 
(solvent B) linear gradient, from 10% to 50% B over 30 
min, at 1.0 mL·min-1 flow rate. Two species were found in 
about the same ratio, named 2a and 2b (see Figure 65, 
Chapter II: Results and discussion). Once the reaction was 
completed, the solvent was removed under vacuum, and 
the products were purified, in order to remove the excess 
of cobalt (II) acetate, by Reverse Phase-Flash 
Chromatography, on a SNAP KP-C18-HS 30 g column, 
eluted with H2O/0.1% TFA (v/v) (solvent A) and 
acetonitrile/0.1% TFA (v/v) (solvent B) linear gradient, 
from 5% to 95% B over 2 column volumes, at 25 mL·min-1 
flow rate. The solvent was then removed under vacuum, 
and the two species were purified to homogeneity by 
preparative RP-HPLC. A Vydac C18 column (22 mm·250 
mm; 10 μm) was used, eluted with H2O/0.1% TFA (v/v) 
(solvent A) and acetonitrile/0.1% TFA (v/v) (solvent B) 
linear gradient, from 10% to 80% B over 58.5 min, at 21 
mL·min-1 flow rate. Pure products were obtained as the 
TFA salt. Reverse phase analytical HPLC coupled with ESI-
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MS confirmed the expected molecular weight (see Figure 
66 and 67, Chapter II: Results and discussion). 
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List of acronyms and abbreviations  
ABTS: 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic 
acid)  
Abs: Absorbance  
Ac: Acetyl  
Aib: 2-amino-2-methylpropanoic acid 
Arg: Arginine  
Asn: Asparagine 
Asp: Aspartic acid  
Boc: t-Butoxycarbonyl  
CD: Circular dichroism  
Cys: Cysteine  
Dab: 2,4-Diaminobutyric acid 
DCM: Dichloromethane  
DIEA: Ethyldiisopropylamine  
DMF: N,N-Dimethylformamide 
DPIX: Deuteroporphyrin IX 
EDT: 1,2-Ethanedithiol  
EPR: Electron paramagnetic resonance 
Eq.: equivalent 
ESI-MS: Electrospray ionization mass spectrometry  
Fmoc: 9-Fluorenylmethoxycarbonyl  
Gln: Glutamine  
Glu: Glutamic acid  
HATU: N-[(Dimethylamino)-1H-1,2,3-triazolo-[4,5-b] 
pyridin- 1-ylmethylene]-N-methylmethanaminium 
hexafluorophosphate N-oxide 
HFIP: 1,1,1,3,3,3-Hexafluoro-2-propanol 
His: Histidine  
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HOBt: N-hydroxybenzotriazole 
HRP: Horseradish peroxidase  
HS: High spin 
Ile: Isoleucine 
IUPAC: International Union of Pure and Applied Chemistry  
Leu: Leucine  
Lys: Lysine  
MCD: Magnetic circular dichroism 
Met: Methionine 
Mmt: (4-methoxyphenyl)diphenylmethyl 
Mtt: (4-methylphenyl)diphenylmethyl 
NMP: N-Methyl-2-pyrrolidone  
NMR: Nuclear magnetic resonance  
Orn: 2,5-Diaminopentanoic acid 
Pbf: 2,2,4,6,7-Pentamethyldihydrobenzofuran-5-sulfonyl  
PDB: Protein Data Bank  
Pro: Proline 
PyBop: (Benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate 
QS: Quantum-mechanical admixed spin 
Rf: Retention factor  
Rt: Retention time 
RMD: Restrained molecular dynamics 
RP-HPLC: Reverse Phase - High Performance Liquid 
Chromatography 
Ser: Serine 
T.O.N.: Turnover number 
tBu: tert-butyl 
TES: Triethylsilane 
TFA: Trifluoroacetic acid  
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TFE: 2,2,2-trifluoroethanol  
Thr: Threonine  
TIS: Triisopropylsilane 
TLC: Thin Layer Chromatography  
Trt: Trityl  
Tyr: Tyrosine 
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to introduce a peroxidase-like activity, by creating a distal 
cavity on the heme. The success with the first asymmetric 
system, Mimochrome VI (MC6), gave the opportunity to 
explore further modifications in order to improve the 
catalytic activity. Starting from ferric MC6, single amino 
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obtain four compounds, which were screened for 
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that an arginine residue in proximity to the heme-distal site 
could assist with catalysis by favoring the formation of the 
intermediate “compound I”, thus mimicking R38 in HRP. 
This result highlights the potential of using small scaffolds 
for exploring the main factors that tune the heme-protein 
activity, and for programming new desired functions. 
*** 
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The functionalization to antibodies of the compounds 
herein described, in order to develop diagnostic devices 
was proposed in “InKidia” business idea and received one  
of the first two Tech Hub 2015 prizes, for the foundation of 
new Start Up Companies. 
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Title. A new Cobalt-Porphyrin mimetic: CoIII-Mimochrome 
VI-2U1L.  
Abstract. Metal ions enclosed in a rigid macrocycle ring 
and axially coordinated by a single nitrogen donor ligand 
are widespread in biological systems as protein cofactors. 
Numerous models were developed to unravel the delicate 
interplay between structure and function in 
metalloproteins and to construct new synthetic functional 
molecules.1 Although there are a number of Co-containing 
enzymes, the biological chemistry of cobalt is dominated by 
the chemistry of cobalamins. Several examples of water-
soluble peptide-based cobalt-porphyrin have been 
reported; they are often characterized by a bis-His 
coordination but only few NMR structures were reported.2 
The Artificial Metallo-Enzyme Group developed a class of 
synthetic heme-protein models: Mimochromes. They are 
porphyrin-peptide conjugates, made up by two peptides, 
covalently linked to the deuteroporphyrin IX. The two 
peptides are in α-helical conformation and cover both 
planes of the heme, resulting in a helix-heme-helix 
sandwich.3 
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The first pentacoordinated model among the Mimochrome 
family, Mimochrome VI, exhibits peroxidase-like activity in 
its iron form.4 Despite the catalytic performance, this 
molecule showed conformational flexibility, which limited a 
complete structural characterization. 
With the aim of enhancing the structural and functional 
properties, new analogues were designed, in which Aib 
residues were inserted at different positions of the peptide 
chains. 
Mimochrome VI-2U1L is the result of a refinement 
procedure, which involved several cycles of molecular 
design, characterization and redesign. This molecule 
exhibits a better peroxidase catalytic performance in its 
ferric form than the parent molecule. In order to better 
understand the structure-function relationship we 
developed the fully diamagnetic compound, CoIII-
Mimochrome VI-2U1L. 
The UV-Vis and CD characterization together with the 
analysis of the NMR structure will be presented. 
(1)  Reedy, C. J.; Gibney, B. R. Chem. Rev. 2004, 104 (2), 617–650. 
(2)  Yonetani, T.; Yamamoto, H.; Woodrow, G. V. J. Biol. Chem. 1974, 
249 (3), 682–690. 
(3)  Lombardi, A.; Nastri, F.; Pavone, V. Chem. Rev. 2001, 101 (10), 
3165–3189. 
(4)  Nastri, F.; Lista, L.; Ringhieri, P.; Vitale, R.; Faiella, M.; Andreozzi, 
C.; Travascio, P.; Maglio, O.; Lombardi, A.; Pavone, V. Chem. - Eur. 
J. 2011, 17 (16), 4444–4453.  
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Title. Developing New Artificial Heme-Enzymes for Catalytic 
Applications. 
 - VII - 
 
Abstract. The Horseradish Peroxidase (HRP) is the most 
representative peroxidase. It is a glycosylated hemeprotein 
able to catalyze the oxidation of a wide range of organic 
compounds using H2O2 as oxidant.1 
In order to mimic HRP, new synthetic models were 
developed: Mimochromes. 
The main features of Mimochromes are the covalent 
structure and a well-defined helical conformation of the 
peptide chains linked to the deuteroporphyrin ring, even in 
the absence of metal ion coordination; the two peptide 
chains cover both planes of the heme, resulting in a helix-
heme-helix sandwich. A minimalist approach was used to 
design short peptide sequences which could serve partly 
the same functions of the protein chain in the natural 
heme-proteins.2 
FeIII-Mimochrome VI is a pentacoordinated model that 
catalyzes the oxidation of several substrates by the 
activation of H2O2.3 The structure of FeIII-Mimochrome VI 
was not resolved because of its conformational flexibility. 
Therefore, new analogues containing amino acidic 
substitutions in key positions of the sequences, were 
designed, with the aim of stabilizing one conformation and 
henceforth improving the catalytic properties. 
In particular, these substitutions were intended to: a) 
increase the helical content of the decapeptide chain 
(introduction of Aib residues), b) decrease the flexibility of 
the linker between the decapeptide chain and the 
porphyrin (substitution of Lys9 with Orn) and c) allow an 
Arg residue to freely participate in the catalytic cycle, 
mimicking Arg38 in HRP (substitution of Glu2 with Leu on 
the tetradecapeptide, preventing Arg10 on the decapeptide 
from forming ionic interaction). 
The resulting molecules were synthesized and 
characterized by UV-Vis spectroscopy and circular 
dichroism; furthermore, their peroxidase-like activity was 
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evaluated toward a reducing substrate, ABTS (2,2'-azino-
bis(3-ethylbenzthiazoline-6-sulphonic acid)). 
(1)  Azevedo, A. M.; Martins, V. C.; Prazeres, D. M. F.; Vojinović, V.; 
Cabral, J. M. S.; Fonseca, L. P. In Biotechnology Annual Review; 
Elsevier, 2003; Vol. 9, pp 199–247. 
(2)  Lombardi, A.; Nastri, F.; Pavone, V. Chem. Rev. 2001, 101 (10), 
3165–3189. 
(3)  Nastri, F.; Lista, L.; Ringhieri, P.; Vitale, R.; Faiella, M.; Andreozzi, 
C.; Travascio, P.; Maglio, O.; Lombardi, A.; Pavone, V. Chem. - Eur. 
J. 2011, 17 (16), 4444–4453. 
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Title. Heme-protein mimics by design: strategies and 
applications. 
Abstract. Heme-proteins take part in a variety of life-
sustaining processes and catalyze difficult reactions with 
efficiency and selectivity that few other natural or artificial 
molecules can achieve.1 For this reason, structural and 
functional studies on heme-proteins have been the focus of 
many years of research. 
The architecture and composition of the protein matrix for 
heme have been selected by Nature in order to allow a 
single prosthetic group to serve numerous and diverse 
chemical functions, such as dioxygen storage and transport, 
electron transfer, hydroxylation and oxidation of organic 
substrates, and hydrogen peroxide disproportion. Variation 
in shape, volume, and chemical composition of the binding 
site, in the mode of heme-binding and in the number and 
nature of hemeprotein interactions, are the main factors 
which contribute to the functional specificity of the heme.2 
 - IX - 
 
Understanding at a molecular level the mechanism by 
which the protein matrix finely tunes the environment of 
the heme is of fundamental importance in both basic and 
applied science.  
Over the years, a large number of low molecular weight 
chemical catalysts has been developed as heme-protein 
mimics.2 They have been basic in elucidating structure and 
function of heme-proteins and heme-enzymes; however, 
they often fail in reproducing several features of 
biocatalysts, such as high turn-over number under mild 
conditions and high selectivity. 
Combining the advantages of chemical and biological 
catalysts would represent a daunting goal for chemists. 
Many efforts have been devoted to the design of peptide-
based heme-protein models.2,3 The design strategy for the 
development of such systems is very challenging, because it 
requires two sets of factors to be taken into account 
simultaneously: (i) the construction of an artificial protein 
that adopts the unique desired folding, and (ii) the 
engineering into the interior of the designed protein of a 
proper cavity able to accommodate the large hydrophobic 
heme. 
Using a structure-based strategy, we have developed a class 
of peptide-porphyrin conjugates, named Mimochromes, to 
investigate the effects of peptide chains composition and 
folding in modulating the properties of the metal ion into 
the porphyrin ring.4,5 The main features of these molecules 
are the covalent structure and the sandwich motif, with two 
helical peptides surrounding the heme on both faces. Our 
recent results on their structural and functional 
characterization will be presented. Their usefulness in 
biomedical and environmental applications, as well in 
biosensor construction, will be particularly highlighted. 
(1)  Lu, Y. Angew. Chem. Int. Ed Engl. 2006, 45 (34), 5588–5601. 
(2)  Lombardi, A.; Nastri, F.; Pavone, V. Chem. Rev. 2001, 101 (10), 
3165–3189. 
 - X - 
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